BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mackay F, Schneider P, Rennert P, Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol. 2003;21:231-264. [PMID: 12427767 DOI: 10.1146/annurev.immunol.21.120601.141152] [Cited by in Crossref: 668] [Cited by in F6Publishing: 593] [Article Influence: 33.4] [Reference Citation Analysis]
Number Citing Articles
1 Jeon S, Kim W, Lee S, Lee M, Park S, Lee S, Kim I, Suk K, Choi BK, Choi EM, Kwon BS, Lee W. Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP‐1 cells. Immunol Cell Biol 2010;88:148-56. [DOI: 10.1038/icb.2009.75] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
2 François A, Gombault A, Villeret B, Alsaleh G, Fanny M, Gasse P, Adam SM, Crestani B, Sibilia J, Schneider P, Bahram S, Quesniaux V, Ryffel B, Wachsmann D, Gottenberg JE, Couillin I. B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis. J Autoimmun 2015;56:1-11. [PMID: 25441030 DOI: 10.1016/j.jaut.2014.08.003] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 6.9] [Reference Citation Analysis]
3 Jonsson MV, Delaleu N, Jonsson R. Animal models of Sjögren's syndrome. Clin Rev Allergy Immunol 2007;32:215-24. [PMID: 17992588 DOI: 10.1007/s12016-007-8012-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
4 Lee GH, Lee J, Lee JW, Choi WS, Moon EY. B cell activating factor-dependent expression of vascular endothelial growth factor in MH7A human synoviocytes stimulated with tumor necrosis factor-α. Int Immunopharmacol 2013;17:142-7. [PMID: 23684916 DOI: 10.1016/j.intimp.2013.04.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
5 Bakry OA, El Shazly RM, Basha MA, Mostafa H. Total serum immunoglobulin E in patients with alopecia areata. Indian Dermatol Online J 2014;5:122-7. [PMID: 24860742 DOI: 10.4103/2229-5178.131076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
6 Blanco-Quirós A, Solís-Sánchez P, Garrote-Adrados JA, Arranz-Sanz E. Common variable immunodeficiency. Old questions are getting clearer. Allergol Immunopathol (Madr) 2006;34:263-75. [PMID: 17173844 DOI: 10.1157/13095875] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
7 Cancro MP. The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation. Immunol Rev 2004;202:237-49. [PMID: 15546397 DOI: 10.1111/j.0105-2896.2004.00212.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
8 Holstein SA, Lunning MA. CAR T‐Cell Therapy in Hematologic Malignancies: A Voyage in Progress. Clin Pharmacol Ther 2019;107:112-22. [DOI: 10.1002/cpt.1674] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 14.0] [Reference Citation Analysis]
9 Li N, Boyd K, Dempsey PJ, Vignali DAA. Non-Cell Autonomous Expression of TNF-α-Converting Enzyme ADAM17 Is Required for Normal Lymphocyte Development. J Immunol 2007;178:4214-21. [DOI: 10.4049/jimmunol.178.7.4214] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
10 De Paepe B, Creus KK, De Bleecker JL. The tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapy. Clin Dev Immunol 2012;2012:369432. [PMID: 22110532 DOI: 10.1155/2012/369432] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
11 Yoshida T, Mei H, Dörner T, Hiepe F, Radbruch A, Fillatreau S, Hoyer BF. Memory B and memory plasma cells. Immunol Rev. 2010;237:117-139. [PMID: 20727033 DOI: 10.1111/j.1600-065x.2010.00938.x] [Cited by in Crossref: 189] [Cited by in F6Publishing: 97] [Article Influence: 17.2] [Reference Citation Analysis]
12 Alsaleh G, François A, Philippe L, Gong YZ, Bahram S, Cetin S, Pfeffer S, Gottenberg JE, Wachsmann D, Georgel P, Sibilia J. MiR-30a-3p negatively regulates BAFF synthesis in systemic sclerosis and rheumatoid arthritis fibroblasts. PLoS One 2014;9:e111266. [PMID: 25360821 DOI: 10.1371/journal.pone.0111266] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
13 Patke A, Mecklenbräuker I, Tarakhovsky A. Survival signaling in resting B cells. Current Opinion in Immunology 2004;16:251-5. [DOI: 10.1016/j.coi.2004.01.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
14 Matthes T, Mckee T, Dunand-sauthier I, Manfroi B, Park S, Passweg J, Huard B. Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow. Leukemia 2015;29:1901-8. [DOI: 10.1038/leu.2015.68] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
15 Maia S, Pelletier M, Ding J, Hsu YM, Sallan SE, Rao SP, Nadler LM, Cardoso AA. Aberrant expression of functional BAFF-system receptors by malignant B-cell precursors impacts leukemia cell survival. PLoS One. 2011;6:e20787. [PMID: 21687682 DOI: 10.1371/journal.pone.0020787] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
16 Nascimento M, Huot-Marchand S, Gombault A, Panek C, Bourinet M, Fanny M, Savigny F, Schneider P, Le Bert M, Ryffel B, Riteau N, Quesniaux VFJ, Couillin I. B-Cell Activating Factor Secreted by Neutrophils Is a Critical Player in Lung Inflammation to Cigarette Smoke Exposure. Front Immunol 2020;11:1622. [PMID: 32849550 DOI: 10.3389/fimmu.2020.01622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Melchers M, Bontjer I, Tong T, Chung NP, Klasse PJ, Eggink D, Montefiori DC, Gentile M, Cerutti A, Olson WC, Berkhout B, Binley JM, Moore JP, Sanders RW. Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses. J Virol 2012;86:2488-500. [PMID: 22205734 DOI: 10.1128/JVI.06259-11] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
18 Jangalwe S, Shultz LD, Mathew A, Brehm MA. Improved B cell development in humanized NOD-scid IL2Rγnull mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3. Immun Inflamm Dis 2016;4:427-40. [PMID: 27980777 DOI: 10.1002/iid3.124] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 9.8] [Reference Citation Analysis]
19 Xie P, Stunz LL, Larison KD, Yang B, Bishop GA. Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. Immunity 2007;27:253-67. [PMID: 17723217 DOI: 10.1016/j.immuni.2007.07.012] [Cited by in Crossref: 149] [Cited by in F6Publishing: 144] [Article Influence: 10.6] [Reference Citation Analysis]
20 Frau J, Coghe G, Lorefice L, Fenu G, Cocco E. New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab. Neuropsychiatr Dis Treat 2018;14:1093-9. [PMID: 29719400 DOI: 10.2147/NDT.S147874] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 3.7] [Reference Citation Analysis]
21 Filipe V, Hawe A, Schellekens H, Jiskoot W. Aggregation and Immunogenicity of Therapeutic Proteins. In: Wang W, Roberts CJ, editors. Aggregation of Therapeutic Proteins. Hoboken: John Wiley & Sons, Inc.; 2010. pp. 403-33. [DOI: 10.1002/9780470769829.ch10] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
22 Nagai M, Hirayama K, Ebihara I, Shimohata H, Kobayashi M, Koyama A. Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity. Nephron Clin Pract 2011;118:c339-45. [PMID: 21293157 DOI: 10.1159/000323393] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
23 Schwab JM, Zhang Y, Kopp MA, Brommer B, Popovich PG. The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury. Exp Neurol 2014;258:121-9. [PMID: 25017893 DOI: 10.1016/j.expneurol.2014.04.023] [Cited by in Crossref: 115] [Cited by in F6Publishing: 110] [Article Influence: 16.4] [Reference Citation Analysis]
24 Almaani S, Rovin BH. B-cell therapy in lupus nephritis: an overview. Nephrol Dial Transplant 2019;34:22-9. [PMID: 30165690 DOI: 10.1093/ndt/gfy267] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
25 Moriyama M, Tanaka A, Maehara T, Furukawa S, Nakashima H, Nakamura S. T helper subsets in Sjögren's syndrome and IgG4-related dacryoadenitis and sialoadenitis: a critical review. J Autoimmun 2014;51:81-8. [PMID: 23920005 DOI: 10.1016/j.jaut.2013.07.007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
26 Castigli E, Wilson SA, Scott S, Dedeoglu F, Xu S, Lam KP, Bram RJ, Jabara H, Geha RS. TACI and BAFF-R mediate isotype switching in B cells. J Exp Med. 2005;201:35-39. [PMID: 15630136 DOI: 10.1084/jem.20032000] [Cited by in Crossref: 379] [Cited by in F6Publishing: 345] [Article Influence: 23.7] [Reference Citation Analysis]
27 Carpenter RO, Evbuomwan MO, Pittaluga S, Rose JJ, Raffeld M, Yang S, Gress RE, Hakim FT, Kochenderfer JN. B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma. Clin Cancer Res 2013;19:2048-60. [PMID: 23344265 DOI: 10.1158/1078-0432.CCR-12-2422] [Cited by in Crossref: 308] [Cited by in F6Publishing: 205] [Article Influence: 38.5] [Reference Citation Analysis]
28 Sun Y, Sun L. CsBAFF, a Teleost B Cell Activating Factor, Promotes Pathogen-Induced Innate Immunity and Vaccine-Induced Adaptive Immunity. PLoS One 2015;10:e0136015. [PMID: 26295165 DOI: 10.1371/journal.pone.0136015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
29 Hunegnaw R, Helmold Hait S, Enyindah-Asonye G, Rahman MA, Ko EJ, Hogge CJ, Hoang T, Robert-Guroff M. A Mucosal Adenovirus Prime/Systemic Envelope Boost Vaccine Regimen Elicits Responses in Cervicovaginal and Alveolar Macrophages of Rhesus Macaques Associated With Delayed SIV Acquisition and B Cell Help. Front Immunol 2020;11:571804. [PMID: 33117363 DOI: 10.3389/fimmu.2020.571804] [Reference Citation Analysis]
30 McCarthy DD, Chiu S, Gao Y, Summers-deLuca LE, Gommerman JL. BAFF induces a hyper-IgA syndrome in the intestinal lamina propria concomitant with IgA deposition in the kidney independent of LIGHT. Cell Immunol 2006;241:85-94. [PMID: 16987502 DOI: 10.1016/j.cellimm.2006.08.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
31 Feigenbaum LZ, Lee D, Ho J. Routine testing of folate levels in geriatric assessment for dementia. J Am Geriatr Soc. 1988;36:755. [PMID: 3136199 DOI: 10.1016/j.cca.2019.07.033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
32 Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J Hepatol. 2013;59:169-177. [PMID: 23542089 DOI: 10.1016/j.jhep.2013.03.018] [Cited by in Crossref: 114] [Cited by in F6Publishing: 116] [Article Influence: 14.3] [Reference Citation Analysis]
33 Janzi M, Melén E, Kull I, Wickman M, Hammarström L. Rare mutations in TNFRSF13B increase the risk of asthma symptoms in Swedish children. Genes Immun 2012;13:59-65. [PMID: 21850030 DOI: 10.1038/gene.2011.55] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
34 Moreaux J, Cremer FW, Reme T, Raab M, Mahtouk K, Kaukel P, Pantesco V, De Vos J, Jourdan E, Jauch A, Legouffe E, Moos M, Fiol G, Goldschmidt H, Rossi JF, Hose D, Klein B. The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 2005;106:1021-30. [PMID: 15827134 DOI: 10.1182/blood-2004-11-4512] [Cited by in Crossref: 188] [Cited by in F6Publishing: 161] [Article Influence: 11.8] [Reference Citation Analysis]
35 de Almeida ERA, Petzl-erler ML. Expression of genes involved in susceptibility to multifactorial autoimmune diseases: estimating genotype effects. Int J Immunogenet 2013;40:178-85. [DOI: 10.1111/j.1744-313x.2012.01152.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
36 Xu H, Samy KP, Guasch A, Mead SI, Ghali A, Mehta A, Stempora L, Kirk AD. Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients. Am J Transplant 2016;16:550-64. [PMID: 26436448 DOI: 10.1111/ajt.13469] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
37 Miller JF. Principles of Immunological Tolerance. Transfus Med Hemother 2005;32:322-31. [DOI: 10.1159/000089119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Sicard T, Kassardjian A, Julien JP. B cell targeting by molecular adjuvants for enhanced immunogenicity. Expert Rev Vaccines 2020;19:1023-39. [PMID: 33252273 DOI: 10.1080/14760584.2020.1857736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
39 He XQ, Guan J, Liu F, Li J, He MR. Identification of the sAPRIL binding peptide and its growth inhibition effects in the colorectal cancer cells. PLoS One 2015;10:e0120564. [PMID: 25826583 DOI: 10.1371/journal.pone.0120564] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
40 Ren K, Jiang T, Zheng X, Zhao G. Proprotein convertase furin/PCSK3 and atherosclerosis: New insights and potential therapeutic targets. Atherosclerosis 2017;262:163-70. [DOI: 10.1016/j.atherosclerosis.2017.04.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
41 Mackay F, Ambrose C. The TNF family members BAFF and APRIL: the growing complexity. Cytokine & Growth Factor Reviews 2003;14:311-24. [DOI: 10.1016/s1359-6101(03)00023-6] [Cited by in Crossref: 116] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
42 Gözmen S, Karapnar TH, Tüfekçi Ö, Vergin C, Yüksel F, İrken G, Ören H. B-cell-activating factor, a proliferation inducing ligand and co-stimulatory molecules in the pathogenesis of immune thrombocytopenia in childhood. Blood Coagul Fibrinolysis 2016;27:494-9. [PMID: 24911453 DOI: 10.1097/MBC.0000000000000144] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Mulazzani M, Huber M, Borchard S, Langer S, Angele B, Schuh E, Meinl E, Dreyling M, Birnbaum T, Straube A, Koedel U, von Baumgarten L. APRIL and BAFF: novel biomarkers for central nervous system lymphoma. J Hematol Oncol 2019;12:102. [PMID: 31615554 DOI: 10.1186/s13045-019-0796-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
44 Lau AWY, Turner VM, Bourne K, Hermes JR, Chan TD, Brink R. BAFFR controls early memory B cell responses but is dispensable for germinal center function. J Exp Med 2021;218:e20191167. [PMID: 33119033 DOI: 10.1084/jem.20191167] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
45 Herishanu Y, Katz BZ, Lipsky A, Wiestner A. Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications. Hematol Oncol Clin North Am 2013;27:173-206. [PMID: 23561469 DOI: 10.1016/j.hoc.2013.01.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 8.3] [Reference Citation Analysis]
46 Tsubata T. B cell abnormality and autoimmune disorders. Autoimmunity 2009;38:331-7. [DOI: 10.1080/08916930500123959] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
47 Lehmann-Horn K, Kronsbein HC, Weber MS. Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges. Ther Adv Neurol Disord 2013;6:161-73. [PMID: 23634189 DOI: 10.1177/1756285612474333] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 7.4] [Reference Citation Analysis]
48 Moon EY, Lee JH, Oh SY, Ryu SK, Kim HM, Kwak HS, Yoon WK. Reactive oxygen species augment B-cell-activating factor expression. Free Radic Biol Med 2006;40:2103-11. [PMID: 16785024 DOI: 10.1016/j.freeradbiomed.2006.02.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
49 Vaziri ND, Pahl MV, Crum A, Norris K. Effect of uremia on structure and function of immune system. J Ren Nutr 2012;22:149-56. [PMID: 22200433 DOI: 10.1053/j.jrn.2011.10.020] [Cited by in Crossref: 172] [Cited by in F6Publishing: 141] [Article Influence: 19.1] [Reference Citation Analysis]
50 Jacobson G, Muncaster S, Mensink K, Forlenza M, Elliot N, Broomfield G, Signal B, Bird S. Omics and cytokine discovery in fish: Presenting the Yellowtail kingfish (Seriola lalandi) as a case study. Developmental & Comparative Immunology 2017;75:63-76. [DOI: 10.1016/j.dci.2017.04.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
51 Sathkumara HD, De Silva NR, Handunnetti S, De Silva AD. Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor. Int J Immunogenet 2015;42:239-53. [DOI: 10.1111/iji.12217] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
52 Eilertsen G, Nossent JC. APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus. Lupus 2014;23:1383-91. [DOI: 10.1177/0961203314543914] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
53 Chan CC, Damen MSMA, Alarcon PC, Sanchez-Gurmaches J, Divanovic S. Inflammation and Immunity: From an Adipocyte's Perspective. J Interferon Cytokine Res 2019;39:459-71. [PMID: 30920343 DOI: 10.1089/jir.2019.0014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
54 Krumbholz M, Specks U, Wick M, Kalled SL, Jenne D, Meinl E. BAFF is elevated in serum of patients with Wegener's granulomatosis. Journal of Autoimmunity 2005;25:298-302. [DOI: 10.1016/j.jaut.2005.08.004] [Cited by in Crossref: 103] [Cited by in F6Publishing: 91] [Article Influence: 6.4] [Reference Citation Analysis]
55 You F, Zhou L, Liu X, Fan J, Ke Z, Ren W. Molecular structure, expression analysis and functional characterization of APRIL (TNFSF13) gene in bat (Vespertilio superans Thomas). Gene 2012;498:196-202. [DOI: 10.1016/j.gene.2012.02.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
56 Sun Q, Jin HJ, Bond JS. Disruption of the meprin alpha and beta genes in mice alters homeostasis of monocytes and natural killer cells. Exp Hematol 2009;37:346-56. [PMID: 19110362 DOI: 10.1016/j.exphem.2008.10.016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
57 Cho SF, Lin L, Xing L, Li Y, Yu T, Anderson KC, Tai YT. BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple Myeloma. Cancers (Basel) 2020;12:E1473. [PMID: 32516895 DOI: 10.3390/cancers12061473] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]
58 van Zelm MC, Berkowska MA, van der Burg M, van Dongen JJ. Real-time quantitative (RQ-)PCR approach to quantify the contribution of proliferation to B lymphocyte homeostasis. Methods Mol Biol 2013;979:133-45. [PMID: 23397393 DOI: 10.1007/978-1-62703-290-2_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Kim KS, Park JY, Jou I, Park SM. Functional implication of BAFF synthesis and release in gangliosides-stimulated microglia. J Leukoc Biol 2009;86:349-59. [PMID: 19406831 DOI: 10.1189/jlb.1008659] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
60 Delaleu N, Jonsson R, Koller MM. Sjogren's syndrome. Eur J Oral Sci 2005;113:101-13. [DOI: 10.1111/j.1600-0722.2004.00183.x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 82] [Article Influence: 6.4] [Reference Citation Analysis]
61 Parodis I, Zickert A, Sundelin B, Axelsson M, Gerhardsson J, Svenungsson E, Malmström V, Gunnarsson I. Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy. Lupus Sci Med 2015;2:e000061. [PMID: 25632350 DOI: 10.1136/lupus-2014-000061] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
62 Ratcliffe MJ, Härtle S. B Cells, the Bursa of Fabricius and the Generation of Antibody Repertoires. Avian Immunology. Elsevier; 2014. pp. 65-89. [DOI: 10.1016/b978-0-12-396965-1.00004-2] [Cited by in Crossref: 12] [Article Influence: 1.7] [Reference Citation Analysis]
63 Banham GD, Flint SM, Torpey N, Lyons PA, Shanahan DN, Gibson A, Watson CJE, O'Sullivan AM, Chadwick JA, Foster KE, Jones RB, Devey LR, Richards A, Erwig LP, Savage CO, Smith KGC, Henderson RB, Clatworthy MR. Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial. Lancet 2018;391:2619-30. [PMID: 29910042 DOI: 10.1016/S0140-6736(18)30984-X] [Cited by in Crossref: 43] [Cited by in F6Publishing: 15] [Article Influence: 14.3] [Reference Citation Analysis]
64 Christensen SR, Shlomchik MJ. Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Semin Immunol 2007;19:11-23. [PMID: 17276080 DOI: 10.1016/j.smim.2006.12.005] [Cited by in Crossref: 119] [Cited by in F6Publishing: 115] [Article Influence: 8.5] [Reference Citation Analysis]
65 Kim SJ, Lee SJ, Choi IY, Park Y, Choi CW, Kim IS, Yu W, Hwang HS, Kim BS. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy. Eur J Haematol 2008;81:177-84. [PMID: 18510703 DOI: 10.1111/j.1600-0609.2008.01099.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
66 Lim JY, Park MJ, Im KI, Kim N, Park HS, Lee SH, Kim EK, Nam YS, Lee ES, Cho ML, Cho SG. Interleukin 21 blockade modulates activated T- and B-cell homeostasis via B-cell activating factor pathway-mediated inhibition in a murine model of acute graft-versus-host disease. Exp Hematol 2015;43:23-31.e1-2. [PMID: 25246268 DOI: 10.1016/j.exphem.2014.09.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
67 Xu W, Santini PA, Matthews AJ, Chiu A, Plebani A, He B, Chen K, Cerutti A. Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF. J Immunol 2008;181:276-87. [PMID: 18566393 DOI: 10.4049/jimmunol.181.1.276] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 6.5] [Reference Citation Analysis]
68 Bergbreiter A, Salzer U. Common variable immunodeficiency: a multifaceted and puzzling disorder. Expert Review of Clinical Immunology 2014;5:167-80. [DOI: 10.1586/1744666x.5.2.167] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
69 Acosta-Rodríguez EV, Craxton A, Hendricks DW, Merino MC, Montes CL, Clark EA, Gruppi A. BAFF and LPS cooperate to induce B cells to become susceptible to CD95/Fas-mediated cell death. Eur J Immunol 2007;37:990-1000. [PMID: 17357108 DOI: 10.1002/eji.200636698] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
70 Lee JJ, Jabara HH, Garibyan L, Rauter I, Sannikova T, Dillon SR, Bram R, Geha RS. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency. J Allergy Clin Immunol 2010;126:1234-41.e2. [PMID: 20889194 DOI: 10.1016/j.jaci.2010.08.017] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
71 Conrad FJ, Rice JS, Cambier JC. Multiple paths to loss of anergy and gain of autoimmunity. Autoimmunity. 2007;40:418-424. [PMID: 17729035 DOI: 10.1080/08916930701464723] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
72 Hubers LM, Maillette de Buy Wenniger LJ, Doorenspleet ME, Klarenbeek PL, Verheij J, Rauws EA, van Gulik TM, Oude Elferink RP, van de Graaf SF, de Vries N. IgG4-associated cholangitis: a comprehensive review. Clin Rev Allergy Immunol. 2015;48:198-206. [PMID: 24958363 DOI: 10.1007/ s12016-014-8430-2] [Reference Citation Analysis]
73 Luu VP, Vazquez MI, Zlotnik A. B cells participate in tolerance and autoimmunity through cytokine production. Autoimmunity 2013;47:1-12. [DOI: 10.3109/08916934.2013.856006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
74 Savioli B, Abdulahad WH, Brouwer E, Kallenberg CG, de Souza AWS. Are cytokines and chemokines suitable biomarkers for Takayasu arteritis? Autoimmunity Reviews 2017;16:1071-8. [DOI: 10.1016/j.autrev.2017.07.023] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 8.5] [Reference Citation Analysis]
75 Cambier JC, Gauld SB, Merrell KT, Vilen BJ. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat Rev Immunol 2007;7:633-43. [PMID: 17641666 DOI: 10.1038/nri2133] [Cited by in Crossref: 238] [Cited by in F6Publishing: 216] [Article Influence: 17.0] [Reference Citation Analysis]
76 Batten M, Fletcher C, Ng LG, Groom J, Wheway J, Laâbi Y, Xin X, Schneider P, Tschopp J, Mackay CR, Mackay F. TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma. J Immunol 2004;172:812-22. [PMID: 14707051 DOI: 10.4049/jimmunol.172.2.812] [Cited by in Crossref: 124] [Cited by in F6Publishing: 112] [Article Influence: 7.3] [Reference Citation Analysis]
77 Groom JR, Fletcher CA, Walters SN, Grey ST, Watt SV, Sweet MJ, Smyth MJ, Mackay CR, Mackay F. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med 2007;204:1959-71. [PMID: 17664289 DOI: 10.1084/jem.20062567] [Cited by in Crossref: 289] [Cited by in F6Publishing: 265] [Article Influence: 20.6] [Reference Citation Analysis]
78 Schrader CE, Linehan EK, Mochegova SN, Woodland RT, Stavnezer J. Inducible DNA breaks in Ig S regions are dependent on AID and UNG. J Exp Med 2005;202:561-8. [PMID: 16103411 DOI: 10.1084/jem.20050872] [Cited by in Crossref: 130] [Cited by in F6Publishing: 124] [Article Influence: 8.1] [Reference Citation Analysis]
79 Novak AJ, Grote DM, Stenson M, Ziesmer SC, Witzig TE, Habermann TM, Harder B, Ristow KM, Bram RJ, Jelinek DF, Gross JA, Ansell SM. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood 2004;104:2247-53. [PMID: 15251985 DOI: 10.1182/blood-2004-02-0762] [Cited by in Crossref: 167] [Cited by in F6Publishing: 142] [Article Influence: 9.8] [Reference Citation Analysis]
80 Giltiay NV, Lu Y, Allman D, Jørgensen TN, Li X. The adaptor molecule Act1 regulates BAFF responsiveness and self-reactive B cell selection during transitional B cell maturation. J Immunol 2010;185:99-109. [PMID: 20543113 DOI: 10.4049/jimmunol.0903312] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
81 Braun T, Juenemann M, Dornes K, El-Shazly J, Schramm P, Bick-Ackerschott S, Kaps M, Gerriets T, Blaes F, Tschernatsch M. BAFF serum and CSF levels in patients with multiple sclerosis and infectious nervous system diseases. Int J Neurosci 2020;:1-6. [PMID: 32602764 DOI: 10.1080/00207454.2020.1784167] [Reference Citation Analysis]
82 Ozcan E, Garibyan L, Lee JJ, Bram RJ, Lam KP, Geha RS. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells. J Allergy Clin Immunol 2009;123:1277-86.e5. [PMID: 19427685 DOI: 10.1016/j.jaci.2009.03.019] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
83 Khlaiphuengsin A, Chuaypen N, Sodsai P, Buranapraditkun S, Boonpiyathad T, Hirankarn N, Tangkijvanich P. Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2020;26:2645-56. [PMID: 32523317 DOI: 10.3748/wjg.v26.i20.2645] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Thorbinson C, Oni L, Smith E, Midgley A, Beresford MW. Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus. Paediatr Drugs 2016;18:181-95. [PMID: 26971103 DOI: 10.1007/s40272-016-0170-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
85 Parameswaran R, Lim M, Fei F, Abdel-Azim H, Arutyunyan A, Schiffer I, McLaughlin ME, Gram H, Huet H, Groffen J, Heisterkamp N. Effector-mediated eradication of precursor B acute lymphoblastic leukemia with a novel Fc-engineered monoclonal antibody targeting the BAFF-R. Mol Cancer Ther 2014;13:1567-77. [PMID: 24825858 DOI: 10.1158/1535-7163.MCT-13-1023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
86 Cornec D, Saraux A, Devauchelle-Pensec V, Clodic C, Pers JO. The future of B cell-targeted therapies in Sjögren’s syndrome. Immunotherapy. 2013;5:639-646. [PMID: 23725286 DOI: 10.2217/imt.13.49] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
87 Lisak RP, Ragheb S. The role of B cell-activating factor in autoimmune myasthenia gravis: BAFF in myasthenia gravis. Annals of the New York Academy of Sciences 2012;1274:60-7. [DOI: 10.1111/j.1749-6632.2012.06842.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
88 Mackay F, Groom JR, Tangye SG. An important role for B-cell activation factor and B cells in the pathogenesis of Sjögren's syndrome. Current Opinion in Rheumatology 2007;19:406-13. [DOI: 10.1097/bor.0b013e328277ef4c] [Cited by in Crossref: 42] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
89 Min JW, Kim KW, Kim BM, Doh KC, Choi MS, Choi BS, Park CW, Yang CW, Kim YS, Oh EJ, Chung BH. Clinical Significance of Pre- and Post-Transplant BAFF Levels in Kidney Transplant Recipients. PLoS One 2016;11:e0162964. [PMID: 27631619 DOI: 10.1371/journal.pone.0162964] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
90 Grivennikov SI, Kuprash DV, Liu ZG, Nedospasov SA. Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms. Int Rev Cytol 2006;252:129-61. [PMID: 16984817 DOI: 10.1016/S0074-7696(06)52002-9] [Cited by in Crossref: 62] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
91 Martinez-Gallo M, Radigan L, Almejún MB, Martínez-Pomar N, Matamoros N, Cunningham-Rundles C. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes. J Allergy Clin Immunol 2013;131:468-76. [PMID: 23237420 DOI: 10.1016/j.jaci.2012.10.029] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
92 Aguirre-Valencia D, Ríos-Serna LJ, Posso-Osorio I, Naranjo-Escobar J, López D, Bedoya-Joaqui V, Nieto-Aristizábal I, Castro AM, Díaz-Ordoñez L, Navarro EP, Barrera MC, Echeverri A, Cañas CA, Tobón GJ. Expression of BAFF, APRIL, and cognate receptor genes in lupus nephritis and potential use as urinary biomarkers. J Transl Autoimmun 2020;3:100027. [PMID: 32743512 DOI: 10.1016/j.jtauto.2019.100027] [Reference Citation Analysis]
93 Shapiro-shelef M, Calame K. Plasma cell differentiation and multiple myeloma. Current Opinion in Immunology 2004;16:226-34. [DOI: 10.1016/j.coi.2004.02.001] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 3.9] [Reference Citation Analysis]
94 Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol. 2009;9:491-502. [PMID: 19521398 DOI: 10.1038/nri2572] [Cited by in Crossref: 593] [Cited by in F6Publishing: 538] [Article Influence: 49.4] [Reference Citation Analysis]
95 Hashiguchi M, Kashiwakura Y, Kanno Y, Kojima H, Kobata T. Tumor necrosis factor superfamily member (TNFSF) 13 (APRIL) and TNFSF13B (BAFF) downregulate homeostatic immunoglobulin production in the intestines. Cellular Immunology 2018;323:41-8. [DOI: 10.1016/j.cellimm.2017.10.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
96 Phares TW, DiSano KD, Stohlman SA, Bergmann CC. Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis. J Virol 2014;88:8853-67. [PMID: 24872583 DOI: 10.1128/JVI.00861-14] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
97 Jo HA, Han SS, Lee S, Kim JY, Yang SH, Lee H, Yang JS, Lee JP, Joo KW, Lim CS, Kim YS, Ahn C, Han JS, Kim DK. The association of tumor necrosis factor superfamily 13 with recurrence of immunoglobulin A nephropathy in living related kidney transplantation. BMC Nephrol 2019;20:33. [PMID: 30704417 DOI: 10.1186/s12882-019-1222-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
98 Deane S, Selmi C, Naguwa SM, Teuber SS, Gershwin ME. Common variable immunodeficiency: etiological and treatment issues. Int Arch Allergy Immunol 2009;150:311-24. [PMID: 19571563 DOI: 10.1159/000226232] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
99 Herbelet S, De Bleecker JL. Immune checkpoint failures in inflammatory myopathies: An overview. Autoimmun Rev 2018;17:746-54. [PMID: 29885538 DOI: 10.1016/j.autrev.2018.01.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
100 Barr TA, Carlring J, Heath AW. CD40 antibody as a potent immunological adjuvant: CD40 antibody provides the CD40 signal to B cells, but does not substitute for T cell help in responses to TD antigens. Vaccine 2005;23:3477-82. [PMID: 15837371 DOI: 10.1016/j.vaccine.2004.12.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
101 Tanna A, Tam FW, Pusey CD. B-cell-targeted therapy in adult glomerulonephritis. Expert Opin Biol Ther. 2013;13:1691-1706. [PMID: 24188581 DOI: 10.1517/14712598.2013.851191] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
102 Chan TD, Gardam S, Gatto D, Turner VM, Silke J, Brink R. In vivo control of B-cell survival and antigen-specific B-cell responses. Immunol Rev 2010;237:90-103. [PMID: 20727031 DOI: 10.1111/j.1600-065X.2010.00942.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
103 Koskela K, Nieminen P, Kohonen P, Salminen H, Lassila O. Chicken B-Cell-Activating Factor: Regulator of B-Cell Survival in the Bursa of Fabricius. Scand J Immunol 2004;59:449-57. [DOI: 10.1111/j.0300-9475.2004.01418.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
104 Chappell CP, Clark EA. Survival niches: B cells get MIFed as well as BAFFled by dendritic cells. Immunol Cell Biol 2008;86:487-8. [DOI: 10.1038/icb.2008.40] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
105 Redmond AK, Pettinello R, Dooley H. Outgroup, alignment and modelling improvements indicate that two TNFSF13-like genes existed in the vertebrate ancestor. Immunogenetics 2017;69:187-92. [PMID: 28070614 DOI: 10.1007/s00251-016-0967-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
106 Cui C, Wang S, Lu W, Wang Y, Li J, Qu K, Yang M, Wang L, Yu Y. The adjuvanticity of manganese for microbial vaccines via activating the IRF5 signaling pathway. Biochem Pharmacol 2021;192:114720. [PMID: 34363796 DOI: 10.1016/j.bcp.2021.114720] [Reference Citation Analysis]
107 Vo HTM, Baudner BC, Sammicheli S, Iannacone M, D'Oro U, Piccioli D. Alum/Toll-Like Receptor 7 Adjuvant Enhances the Expansion of Memory B Cell Compartment Within the Draining Lymph Node. Front Immunol 2018;9:641. [PMID: 29686670 DOI: 10.3389/fimmu.2018.00641] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
108 Hajishengallis G, Chavakis T, Lambris JD. Current understanding of periodontal disease pathogenesis and targets for host-modulation therapy. Periodontol 2000 2020;84:14-34. [PMID: 32844416 DOI: 10.1111/prd.12331] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 24.0] [Reference Citation Analysis]
109 Mathian A, Weinberg A, Gallegos M, Banchereau J, Koutouzov S. IFN-α Induces Early Lethal Lupus in Preautoimmune (New Zealand Black × New Zealand White)F 1 but Not in BALB/c Mice. J Immunol 2005;174:2499-506. [DOI: 10.4049/jimmunol.174.5.2499] [Cited by in Crossref: 202] [Cited by in F6Publishing: 188] [Article Influence: 12.6] [Reference Citation Analysis]
110 Liu X, Ji XM, Du XN, Zong XC, Liang DF, Ma L, Wu HT, Zhang SQ. Molecular cloning, expression, bioinformatics analysis, and bioactivity of TNFSF13 (APRIL) in the South African clawed frog (Xenopus laevi): a new model to study immunological diseases. OMICS 2013;17:384-92. [PMID: 23829578 DOI: 10.1089/omi.2013.0004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
111 Pathak S, Ma S, Shukla V, Lu R. A role for IRF8 in B cell anergy. J Immunol 2013;191:6222-30. [PMID: 24218455 DOI: 10.4049/jimmunol.1301169] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
112 Kuo SH, Yeh PY, Chen LT, Wu MS, Lin CW, Yeh KH, Tzeng YS, Chen JY, Hsu PN, Lin JT. Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma. Blood. 2008;112:2927-2934. [PMID: 18628489 DOI: 10.1182/blood-2008-02-137513] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
113 den Haan JM, Arens R, van Zelm MC. The activation of the adaptive immune system: Cross-talk between antigen-presenting cells, T cells and B cells. Immunology Letters 2014;162:103-12. [DOI: 10.1016/j.imlet.2014.10.011] [Cited by in Crossref: 59] [Cited by in F6Publishing: 42] [Article Influence: 8.4] [Reference Citation Analysis]
114 Corcoran L, Emslie D, Kratina T, Shi W, Hirsch S, Taubenheim N, Chevrier S. Oct2 and Obf1 as Facilitators of B:T Cell Collaboration during a Humoral Immune Response. Front Immunol 2014;5:108. [PMID: 24688485 DOI: 10.3389/fimmu.2014.00108] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
115 Lied GA, Berstad A. Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative review. Scand J Immunol. 2011;73:1-7. [PMID: 21128997 DOI: 10.1111/j.1365-3083.2010.02470.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 5.5] [Reference Citation Analysis]
116 Gu D, Ge J, Du W, Xue F, Chen Z, Zhao H, Zhou Z, Xu J, Liu P, Zhao Q, Zhang L, Yang R. Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications. Autoimmunity 2009;42:692-8. [DOI: 10.3109/08916930903214025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
117 Banga JP, Nielsen CH, Gilbert JA, El Fassi D, Hegedus L. Application of New Therapies in Graves' Disease and Thyroid-Associated Ophthalmopathy: Animal Models and Translation to Human Clinical Trials. Thyroid 2008;18:973-81. [DOI: 10.1089/thy.2007.0406] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
118 Lenert A, Lenert P. Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents. Drug Des Devel Ther 2015;9:333-47. [PMID: 25609919 DOI: 10.2147/DDDT.S67264] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
119 Kim J, Gross JA, Dillon SR, Min J, Elkon KB. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation. Autoimmunity 2011;44:69-81. [DOI: 10.3109/08916934.2010.509122] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
120 George-Chandy A, Trysberg E, Eriksson K. Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms. Arthritis Res Ther 2008;10:R97. [PMID: 18718031 DOI: 10.1186/ar2484] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
121 Hubers LM, Maillette de Buy Wenniger LJ, Doorenspleet ME, Klarenbeek PL, Verheij J, Rauws EA, van Gulik TM, Oude Elferink RPJ, van de Graaf SFJ, de Vries N, Beuers U. IgG4-Associated Cholangitis: A Comprehensive Review. Clinic Rev Allerg Immunol 2015;48:198-206. [DOI: 10.1007/s12016-014-8430-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
122 Abe T, AlSarhan M, Benakanakere MR, Maekawa T, Kinane DF, Cancro MP, Korostoff JM, Hajishengallis G. The B Cell-Stimulatory Cytokines BLyS and APRIL Are Elevated in Human Periodontitis and Are Required for B Cell-Dependent Bone Loss in Experimental Murine Periodontitis. J Immunol 2015;195:1427-35. [PMID: 26150532 DOI: 10.4049/jimmunol.1500496] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 6.7] [Reference Citation Analysis]
123 Sasaki Y, Casola S, Kutok JL, Rajewsky K, Schmidt-Supprian M. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol 2004;173:2245-52. [PMID: 15294936 DOI: 10.4049/jimmunol.173.4.2245] [Cited by in Crossref: 270] [Cited by in F6Publishing: 257] [Article Influence: 15.9] [Reference Citation Analysis]
124 Tezuka H, Abe Y, Asano J, Sato T, Liu J, Iwata M, Ohteki T. Prominent role for plasmacytoid dendritic cells in mucosal T cell-independent IgA induction. Immunity. 2011;34:247-257. [PMID: 21333555 DOI: 10.1016/j.immuni.2011.02.002] [Cited by in Crossref: 151] [Cited by in F6Publishing: 135] [Article Influence: 15.1] [Reference Citation Analysis]
125 Banham G, Prezzi D, Harford S, Taylor CJ, Hamer R, Higgins R, Bradley JA, Clatworthy MR. Elevated pretransplantation soluble BAFF is associated with an increased risk of acute antibody-mediated rejection. Transplantation. 2013;96:413-420. [PMID: 23842189 DOI: 10.1097/tp.0b013e318298dd65] [Cited by in Crossref: 50] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
126 Raffaghello L, Fuhlhuber V, Bianchi G, Conte M, Blaes F, Gambini C, Pistoia V. Role of BAFF in Opsoclonus-Myoclonus syndrome, a bridge between cancer and autoimmunity. Journal of Leukocyte Biology 2013;94:183-91. [DOI: 10.1189/jlb.0213106] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
127 Wolf AI, Mozdzanowska K, Quinn WJ 3rd, Metzgar M, Williams KL, Caton AJ, Meffre E, Bram RJ, Erickson LD, Allman D, Cancro MP, Erikson J. Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI. J Clin Invest 2011;121:3954-64. [PMID: 21881204 DOI: 10.1172/JCI57362] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
128 Su DL, Lu ZM, Shen MN, Li X, Sun LY. Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE. J Biomed Biotechnol 2012;2012:347141. [PMID: 22500087 DOI: 10.1155/2012/347141] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 9.0] [Reference Citation Analysis]
129 Delaleu N, Jonsson MV, Jonsson R. Disease mechanisms of Sjögren's syndrome. Drug Discovery Today: Disease Mechanisms 2004;1:329-36. [DOI: 10.1016/j.ddmec.2004.11.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
130 Qian Y, Giltiay N, Xiao J, Wang Y, Tian J, Han S, Scott M, Carter R, Jorgensen TN, Li X. Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjögren's syndrome. Eur J Immunol 2008;38:2219-28. [PMID: 18624351 DOI: 10.1002/eji.200738113] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 4.0] [Reference Citation Analysis]
131 Delaleu N, Jonsson MV, Appel S, Jonsson R. New Concepts in the Pathogenesis of Sjögren's Syndrome. Rheumatic Disease Clinics of North America 2008;34:833-45. [DOI: 10.1016/j.rdc.2008.08.004] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
132 Eibel H, Kraus H, Sic H, Kienzler AK, Rizzi M. B cell biology: an overview. Curr Allergy Asthma Rep 2014;14:434. [PMID: 24633618 DOI: 10.1007/s11882-014-0434-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
133 Mccullough KC, Summerfield A. Basic Concepts of Immune Response and Defense Development. ILAR Journal 2005;46:230-40. [DOI: 10.1093/ilar.46.3.230] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
134 Rodríguez-Lobato LG, Ganzetti M, Fernández de Larrea C, Hudecek M, Einsele H, Danhof S. CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions. Front Oncol 2020;10:1243. [PMID: 32850376 DOI: 10.3389/fonc.2020.01243] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 24.0] [Reference Citation Analysis]
135 Gui L, Zeng Q, Xu Z, Zhang H, Qin S, Liu C, Xu C, Qian Z, Zhang S, Huang S, Chen L. IL-2, IL-4, IFN-γ or TNF-α enhances BAFF-stimulated cell viability and survival by activating Erk1/2 and S6K1 pathways in neoplastic B-lymphoid cells. Cytokine 2016;84:37-46. [PMID: 27235588 DOI: 10.1016/j.cyto.2016.05.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
136 Castigli E, Geha RS. TACI, isotype switching, CVID and IgAD. Immunol Res 2007;38:102-11. [PMID: 17917015 DOI: 10.1007/s12026-007-8000-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
137 Goodnow CC, Sprent J, Fazekas de St Groth B, Vinuesa CG. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005;435:590-7. [PMID: 15931211 DOI: 10.1038/nature03724] [Cited by in Crossref: 473] [Cited by in F6Publishing: 399] [Article Influence: 29.6] [Reference Citation Analysis]
138 Brown KD, Estefania Claudio, and Ulrich Siebenlist. The Roles of the Classical and Alternative Nuclear Factor-kappaB Pathways: Potential Implications for Autoimmunity and Rheumatoid Arthritis. Arthritis Research Therapy. 2008;10:212. [PMID: 18771589 DOI: 10.1186/ar2457] [Cited by in Crossref: 163] [Cited by in F6Publishing: 152] [Article Influence: 12.5] [Reference Citation Analysis]
139 Hasler P, Zouali M. B lymphocytes as therapeutic targets in systemic lupus erythematosus. Expert Opinion on Therapeutic Targets 2006;10:803-15. [DOI: 10.1517/14728222.10.6.803] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
140 Moon EY, Yi KY, Lee S. An increase in B cell apoptosis by interfering BAFF-BAFF-R interaction with small synthetic molecules. Int Immunopharmacol 2011;11:1523-33. [PMID: 21620999 DOI: 10.1016/j.intimp.2011.05.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
141 Zhou L, Zhong R, Hao W, Wang H, Fan X, Zhang L, Mi Q. Interleukin-10 and interferon-gamma up-regulate the expression of B-cell activating factor in cultured human promyelocytic leukemia cells. Exp Mol Pathol 2009;87:54-8. [PMID: 19393234 DOI: 10.1016/j.yexmp.2009.04.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
142 Lee SH, Choi JH. Involvement of Immune Cell Network in Aortic Valve Stenosis: Communication between Valvular Interstitial Cells and Immune Cells. Immune Netw 2016;16:26-32. [PMID: 26937229 DOI: 10.4110/in.2016.16.1.26] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
143 Craxton A, Draves KE, Gruppi A, Clark EA. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J Exp Med 2005;202:1363-74. [PMID: 16301744 DOI: 10.1084/jem.20051283] [Cited by in Crossref: 144] [Cited by in F6Publishing: 131] [Article Influence: 9.6] [Reference Citation Analysis]
144 Borhis G, Trovato M, Ibrahim HM, Isnard S, Le Grand R, Bosquet N, Richard Y. Impact of BAFF Blockade on Inflammation, Germinal Center Reaction and Effector B-Cells During Acute SIV Infection. Front Immunol 2020;11:252. [PMID: 32194549 DOI: 10.3389/fimmu.2020.00252] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
145 Zhang P, Liu X, Guo A, Xiong J, Fu Y, Zou K. B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease. Dig Dis Sci 2016;61:2608-18. [DOI: 10.1007/s10620-016-4136-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
146 Gu S, Sayad A, Chan G, Yang W, Lu Z, Virtanen C, Van Etten RA, Neel BG. SHP2 is required for BCR-ABL1-induced hematologic neoplasia. Leukemia 2018;32:203-13. [PMID: 28804122 DOI: 10.1038/leu.2017.250] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
147 Ng LG, Sutherland AP, Newton R, Qian F, Cachero TG, Scott ML, Thompson JS, Wheway J, Chtanova T, Groom J, Sutton IJ, Xin C, Tangye SG, Kalled SL, Mackay F, Mackay CR. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol. 2004;173:807-817. [PMID: 15240667 DOI: 10.4049/jimmunol.173.2.807] [Cited by in Crossref: 339] [Cited by in F6Publishing: 319] [Article Influence: 19.9] [Reference Citation Analysis]
148 Vugmeyster Y, Howell K, Bakshi A, Flores C, Hwang O, McKeever K. B-cell subsets in blood and lymphoid organs in Macaca fascicularis. Cytometry A 2004;61:69-75. [PMID: 15351991 DOI: 10.1002/cyto.a.20039] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
149 Liu HZ, Song R, Zhang JX, Li JF, Gu W, Zhang SQ. Molecular Cloning, Recombinant Expression, and Funtional Characterization of APRIL (TNFSF13) in Cat (felis catus). Anim Biotechnol 2016;27:1-8. [PMID: 26485397 DOI: 10.1080/10495398.2014.977906] [Reference Citation Analysis]
150 Hegazy M, Darwish H, Darweesh H, El-shehaby A, Emad Y. Raised serum level of APRIL in patients with systemic lupus erythematosus: Correlations with disease activity indices. Clinical Immunology 2010;135:118-24. [DOI: 10.1016/j.clim.2009.12.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
151 Cho SF, Anderson KC, Tai YT. Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy. Front Immunol 2018;9:1821. [PMID: 30147690 DOI: 10.3389/fimmu.2018.01821] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 36.0] [Reference Citation Analysis]
152 Stypińska B, Paradowska-Gorycka A. Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus. Int J Mol Sci 2015;16:24194-218. [PMID: 26473848 DOI: 10.3390/ijms161024194] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
153 Planelles L, Carvalho-Pinto CE, Hardenberg G, Smaniotto S, Savino W, Gómez-Caro R, Alvarez-Mon M, de Jong J, Eldering E, Martínez-A C, Medema JP, Hahne M. APRIL promotes B-1 cell-associated neoplasm. Cancer Cell 2004;6:399-408. [PMID: 15488762 DOI: 10.1016/j.ccr.2004.08.033] [Cited by in Crossref: 109] [Cited by in F6Publishing: 98] [Article Influence: 6.4] [Reference Citation Analysis]
154 Xu AQ, Barbosa RR, Calado DP. Genetic timestamping of plasma cells in vivo reveals tissue-specific homeostatic population turnover. Elife 2020;9:e59850. [PMID: 33136000 DOI: 10.7554/eLife.59850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Lim SG, Kim JK, Suk K, Lee WH. Crosstalk between signals initiated from TLR4 and cell surface BAFF results in synergistic induction of proinflammatory mediators in THP-1 cells. Sci Rep 2017;7:45826. [PMID: 28374824 DOI: 10.1038/srep45826] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
156 Hopia L, Thangarajh M, Khademi M, Laveskog A, Wallström E, Svenungsson E, Andersson M. Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus. Scandinavian Journal of Rheumatology 2011;40:363-72. [DOI: 10.3109/03009742.2010.550900] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
157 Pallikkuth S, Kanthikeel SP, Silva SY, Fischl M, Pahwa R, Pahwa S. Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients. J Allergy Clin Immunol 2011;128:1279-85. [PMID: 21752440 DOI: 10.1016/j.jaci.2011.05.033] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
158 Chen L, Ran MJ, Shan XX, Cao M, Cao P, Yang XM, Zhang SQ. BAFF enhances B-cell-mediated immune response and vaccine-protection against a very virulent IBDV in chickens. Vaccine 2009;27:1393-9. [DOI: 10.1016/j.vaccine.2008.12.040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
159 Melissaropoulos K, Daoussis D. B cells in systemic sclerosis: from pathophysiology to treatment. Clin Rheumatol 2021;40:2621-31. [PMID: 33745085 DOI: 10.1007/s10067-021-05665-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Kolfschoten GM, Pradet-balade B, Hahne M, Medema JP. TWE-PRIL; a fusion protein of TWEAK and APRIL. Biochemical Pharmacology 2003;66:1427-32. [DOI: 10.1016/s0006-2952(03)00493-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
161 Cáceres CJ, Cardenas-Garcia S, Jain A, Gay LC, Carnaccini S, Seibert B, Ferreri LM, Geiger G, Jasinskas A, Nakajima R, Rajao DS, Isakova-Sivak I, Rudenko L, Vincent AL, Davies DH, Perez DR. Development of a Novel Live Attenuated Influenza A Virus Vaccine Encoding the IgA-Inducing Protein. Vaccines (Basel) 2021;9:703. [PMID: 34198994 DOI: 10.3390/vaccines9070703] [Reference Citation Analysis]
162 Cohen S, Shachar I. Cytokines as regulators of proliferation and survival of healthy and malignant peripheral B cells. Cytokine 2012;60:13-22. [PMID: 22784632 DOI: 10.1016/j.cyto.2012.06.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
163 Hamza N, Bos NA, Kallenberg CG. B-cell populations and sub-populations in Sjögren's syndrome. La Presse Médicale 2012;41:e475-83. [DOI: 10.1016/j.lpm.2012.05.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
164 Catalán D, Mansilla MA, Ferrier A, Soto L, Oleinika K, Aguillón JC, Aravena O. Immunosuppressive Mechanisms of Regulatory B Cells. Front Immunol 2021;12:611795. [PMID: 33995344 DOI: 10.3389/fimmu.2021.611795] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
165 Parameswaran R, Müschen M, Kim YM, Groffen J, Heisterkamp N. A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias. Cancer Res 2010;70:4346-56. [PMID: 20460528 DOI: 10.1158/0008-5472.CAN-10-0300] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
166 Vallerskog T, Heimbürger M, Gunnarsson I, Zhou W, Wahren-Herlenius M, Trollmo C, Malmström V. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther 2006;8:R167. [PMID: 17092341 DOI: 10.1186/ar2076] [Cited by in Crossref: 121] [Cited by in F6Publishing: 114] [Article Influence: 8.6] [Reference Citation Analysis]
167 Basha S, Pichichero ME. Decreased TNF family receptor expression on B-cells is associated with reduced humoral responses to Streptococcus pneumoniae infections in young children. Cell Immunol 2017;320:11-9. [PMID: 28947093 DOI: 10.1016/j.cellimm.2017.07.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
168 Lee J, Yoon SS, Thuy PX, Moon EY. Synovial Cell Migration is Associated with B Cell Activating Factor Expression Increased by TNFα or Decreased by KR33426. Biomol Ther (Seoul) 2020;28:405-13. [PMID: 32753567 DOI: 10.4062/biomolther.2020.110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
169 Shimomura Y, Ogawa A, Kawada M, Sugimoto K, Mizoguchi E, Shi HN, Pillai S, Bhan AK, Mizoguchi A. A unique B2 B cell subset in the intestine. J Exp Med 2008;205:1343-55. [PMID: 18519649 DOI: 10.1084/jem.20071572] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
170 Fujii H, Cuvelier G, She K, Aslanian S, Shimizu H, Kariminia A, Krailo M, Chen Z, McMaster R, Bergman A. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children’s Oncology Group. Blood. 2008;111:3276-3285. [PMID: 17925486 DOI: 10.1182/blood-2007-08-106286] [Cited by in Crossref: 107] [Cited by in F6Publishing: 94] [Article Influence: 7.6] [Reference Citation Analysis]
171 Kato A, Truong-Tran AQ, Scott AL, Matsumoto K, Schleimer RP. Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent mechanism. J Immunol 2006;177:7164-72. [PMID: 17082634 DOI: 10.4049/jimmunol.177.10.7164] [Cited by in Crossref: 117] [Cited by in F6Publishing: 106] [Article Influence: 8.4] [Reference Citation Analysis]
172 Miraghazadeh B, Cook MC. Nuclear Factor-kappaB in Autoimmunity: Man and Mouse. Front Immunol 2018;9:613. [PMID: 29686669 DOI: 10.3389/fimmu.2018.00613] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 14.7] [Reference Citation Analysis]
173 Peng HL, Zhang Y, Sun NN, Yin YF, Wang YW, Cheng Z, Yan WZ, Liu SF, Xu YX, Xiao X, Zhang GS. A gain-of-function mutation in TNFRSF13B is a candidate for predisposition to familial or sporadic immune thrombocytopenia. J Thromb Haemost 2017;15:2259-69. [PMID: 28834165 DOI: 10.1111/jth.13806] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
174 Yehudai D, Snir A, Peri R, Halasz K, Haj T, Odeh M, Kessel A. B cell-activating factor enhances interleukin-6 and interleukin-10 production by ODN-activated human B cells. Scand J Immunol 2012;76:371-7. [PMID: 22725135 DOI: 10.1111/j.1365-3083.2012.02752.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
175 Chiu A, Xu W, He B, Dillon SR, Gross JA, Sievers E, Qiao X, Santini P, Hyjek E, Lee JW, Cesarman E, Chadburn A, Knowles DM, Cerutti A. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL. Blood 2007;109:729-39. [PMID: 16960154 DOI: 10.1182/blood-2006-04-015958] [Cited by in Crossref: 142] [Cited by in F6Publishing: 116] [Article Influence: 9.5] [Reference Citation Analysis]
176 Hajek AR, Lindley AR, Favoreto S Jr, Carter R, Schleimer RP, Kuperman DA. 12/15-Lipoxygenase deficiency protects mice from allergic airways inflammation and increases secretory IgA levels. J Allergy Clin Immunol 2008;122:633-9.e3. [PMID: 18692885 DOI: 10.1016/j.jaci.2008.06.021] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
177 Beinke S, Ley SC. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J 2004;382:393-409. [PMID: 15214841 DOI: 10.1042/BJ20040544] [Cited by in Crossref: 421] [Cited by in F6Publishing: 174] [Article Influence: 26.3] [Reference Citation Analysis]
178 Gor DO, Ding X, Li Q, Sultana D, Mambula SS, Bram RJ, Greenspan NS. Enhanced immunogenicity of pneumococcal surface adhesin A (PsaA) in mice via fusion to recombinant human B lymphocyte stimulator (BLyS). Biol Direct 2011;6:9. [PMID: 21306646 DOI: 10.1186/1745-6150-6-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
179 Mutoh T, Ishii T, Shirai T, Akita K, Kamogawa Y, Fujita Y, Sato H, Shirota Y, Fujii H, Harigae H. Refractory Takayasu arteritis successfully treated with rituximab: case-based review. Rheumatol Int 2019;39:1989-94. [PMID: 31388749 DOI: 10.1007/s00296-019-04390-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
180 Golbin JM, Specks U. Targeting B lymphocytes as therapy for ANCA-associated vasculitis. Rheum Dis Clin North Am 2007;33:741-54, v. [PMID: 18037114 DOI: 10.1016/j.rdc.2007.09.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
181 Min JW, Shin YJ, Lee H, Kim BM, Park KH, Doh KC, Kim TM, Lim SW, Yang CW, Oh EJ, Chung BH. BAFF Inhibition Effectively Suppresses the Development of Anti-HLA.A2 Antibody in the Highly Sensitized Mouse Model. Int J Mol Sci 2021;22:E861. [PMID: 33467096 DOI: 10.3390/ijms22020861] [Reference Citation Analysis]
182 Cornec D, Devauchelle-Pensec V, Tobón GJ, Pers JO, Jousse-Joulin S, Saraux A. B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun 2012;39:161-7. [PMID: 22749831 DOI: 10.1016/j.jaut.2012.05.014] [Cited by in Crossref: 100] [Cited by in F6Publishing: 87] [Article Influence: 11.1] [Reference Citation Analysis]
183 Chang Y, Jia X, Sun X, Xu S, Wu Y, Zhang L, Wei W. APRIL promotes proliferation, secretion and invasion of fibroblast-like synoviocyte from rats with adjuvant induced arthritis. Molecular Immunology 2015;64:90-8. [DOI: 10.1016/j.molimm.2014.11.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
184 Wang H, Clarke SH. Regulation of B-cell development by antibody specificity. Curr Opin Immunol 2004;16:246-50. [PMID: 15023420 DOI: 10.1016/j.coi.2004.01.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
185 Hajishengallis G. New developments in neutrophil biology and periodontitis. Periodontol 2000 2020;82:78-92. [DOI: 10.1111/prd.12313] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
186 Bader L, Koldingsnes W, Nossent J. B-lymphocyte activating factor levels are increased in patients with Wegener's granulomatosis and inversely correlated with ANCA titer. Clin Rheumatol 2010;29:1031-5. [PMID: 20582728 DOI: 10.1007/s10067-010-1526-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
187 Zhang M, Ko KH, Lam QL, Lo CK, Srivastava G, Zheng B, Lau YL, Lu L. Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis. Int Immunol 2005;17:1081-92. [PMID: 16000326 DOI: 10.1093/intimm/dxh287] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
188 Zhao Z, Burkly LC, Campbell S, Schwartz N, Molano A, Choudhury A, Eisenberg RA, Michaelson JS, Putterman C. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus. J Immunol 2007;179:7949-58. [PMID: 18025243 DOI: 10.4049/jimmunol.179.11.7949] [Cited by in Crossref: 118] [Cited by in F6Publishing: 109] [Article Influence: 9.1] [Reference Citation Analysis]
189 Bacchelli C, Buckridge S, Thrasher AJ, Gaspar HB. Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency. Clin Exp Immunol 2007;149:401-9. [PMID: 17697196 DOI: 10.1111/j.1365-2249.2007.03461.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
190 Hessels AC, Sanders JSF, Rutgers A, Stegeman CA. Gene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitis. Pharmacogenomics J 2020;20:749-59. [DOI: 10.1038/s41397-020-0176-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
191 Nimmanapalli R, Lyu MA, Du M, Keating MJ, Rosenblum MG, Gandhi V. The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cells. Blood 2007;109:2557-64. [PMID: 17119117 DOI: 10.1182/blood-2006-08-042424] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
192 Panchanathan R, Choubey D. Murine BAFF expression is up-regulated by estrogen and interferons: implications for sex bias in the development of autoimmunity. Mol Immunol 2013;53:15-23. [PMID: 22784990 DOI: 10.1016/j.molimm.2012.06.013] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 7.2] [Reference Citation Analysis]
193 Kimberley FC, van der Sloot AM, Guadagnoli M, Cameron K, Schneider P, Marquart JA, Versloot M, Serrano L, Medema JP. The design and characterization of receptor-selective APRIL variants. J Biol Chem 2012;287:37434-46. [PMID: 22961987 DOI: 10.1074/jbc.M112.406090] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
194 Gottenberg JE, Sellam J, Ittah M, Lavie F, Proust A, Zouali H, Sordet C, Sibilia J, Kimberly RP, Mariette X, Miceli-Richard C. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome. Arthritis Res Ther 2006;8:R30. [PMID: 16507129 DOI: 10.1186/ar1884] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
195 Becker YT, Samaniego-Picota M, Sollinger HW. The emerging role of rituximab in organ transplantation. Transpl Int. 2006;19:621-628. [PMID: 16827678 DOI: 10.1111/j.1432-2277.2006.00345.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
196 Li K, McGee LR, Fisher B, Sudom A, Liu J, Rubenstein SM, Anwer MK, Cushing TD, Shin Y, Ayres M, Lee F, Eksterowicz J, Faulder P, Waszkowycz B, Plotnikova O, Farrelly E, Xiao SH, Chen G, Wang Z. Inhibiting NF-κB-inducing kinase (NIK): discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structures. Bioorg Med Chem Lett 2013;23:1238-44. [PMID: 23374866 DOI: 10.1016/j.bmcl.2013.01.012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
197 Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Ann Rheum Dis 2007;66:790-7. [PMID: 17185325 DOI: 10.1136/ard.2006.065656] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
198 Frasca D, Riley RL, Blomberg BB. Aging murine B cells have decreased class switch induced by anti-CD40 or BAFF. Exp Gerontol 2007;42:192-203. [PMID: 17067770 DOI: 10.1016/j.exger.2006.09.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
199 Kang S, Keener AB, Jones SZ, Benschop RJ, Caro-Maldonado A, Rathmell JC, Clarke SH, Matsushima GK, Whitmire JK, Vilen BJ. IgG-Immune Complexes Promote B Cell Memory by Inducing BAFF. J Immunol 2016;196:196-206. [PMID: 26621863 DOI: 10.4049/jimmunol.1402527] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
200 Nagel A, Podstawa E, Eickmann M, Müller HH, Hertl M, Eming R. Rituximab mediates a strong elevation of B-cell-activating factor associated with increased pathogen-specific IgG but not autoantibodies in pemphigus vulgaris. J Invest Dermatol 2009;129:2202-10. [PMID: 19282839 DOI: 10.1038/jid.2009.27] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
201 Boulé MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, Rifkin IR. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 2004;199:1631-40. [PMID: 15197227 DOI: 10.1084/jem.20031942] [Cited by in Crossref: 396] [Cited by in F6Publishing: 368] [Article Influence: 23.3] [Reference Citation Analysis]
202 Ma DY, Clark EA. The role of CD40 and CD154/CD40L in dendritic cells. Semin Immunol. 2009;21:265-272. [PMID: 19524453 DOI: 10.1016/j.smim.2009.05.010] [Cited by in Crossref: 218] [Cited by in F6Publishing: 206] [Article Influence: 18.2] [Reference Citation Analysis]
203 Liu K, Zhang Y, Hu S, Yu Y, Yang Q, Jin D, Chen X, Jin Q, Liu H. Increased levels of BAFF and APRIL related to human active pulmonary tuberculosis. PLoS One 2012;7:e38429. [PMID: 22719887 DOI: 10.1371/journal.pone.0038429] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
204 Hsu J, Peters AT. Pathophysiology of Chronic Rhinosinusitis with Nasal Polyp. Am J Rhinol�Allergy 2011;25:285-90. [DOI: 10.2500/ajra.2011.25.3680] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 6.8] [Reference Citation Analysis]
205 Subbian S, Tsenova L, Yang G, O'Brien P, Parsons S, Peixoto B, Taylor L, Fallows D, Kaplan G. Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response. Open Biol 2011;1:110016. [PMID: 22645653 DOI: 10.1098/rsob.110016] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 9.1] [Reference Citation Analysis]
206 Lee SM, Kim EJ, Suk K, Lee WH. Synthetic peptides containing ITIM-like sequences of IREM-1 inhibit BAFF-mediated regulation of interleukin-8 expression and phagocytosis through SHP-1 and/or PI3K. Immunology 2011;134:224-33. [PMID: 21896016 DOI: 10.1111/j.1365-2567.2011.03481.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
207 Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F, Brink R. Excess BAFF Rescues Self-Reactive B Cells from Peripheral Deletion and Allows Them to Enter Forbidden Follicular and Marginal Zone Niches. Immunity 2004;20:785-98. [DOI: 10.1016/j.immuni.2004.05.010] [Cited by in Crossref: 517] [Cited by in F6Publishing: 481] [Article Influence: 30.4] [Reference Citation Analysis]
208 Cui XW, Li JF, Xiao W, Xuan Y, Tian AY, Xu XZ, Zhang SQ. Molecular cloning, expression and functional analysis of TNF13b (BAFF) in Japanese sea perch, Lateolabrax japonicus. Int Immunopharmacol 2012;12:34-41. [PMID: 22032840 DOI: 10.1016/j.intimp.2011.10.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
209 Jankovic M, Robbiani DF, Dorsett Y, Eisenreich T, Xu Y, Tarakhovsky A, Nussenzweig A, Nussenzweig MC. Role of the translocation partner in protection against AID-dependent chromosomal translocations. Proc Natl Acad Sci U S A 2010;107:187-92. [PMID: 19966290 DOI: 10.1073/pnas.0908946107] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
210 Qian Y, Qin J, Cui G, Naramura M, Snow EC, Ware CF, Fairchild RL, Omori SA, Rickert RC, Scott M, Kotzin BL, Li X. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity 2004;21:575-87. [PMID: 15485634 DOI: 10.1016/j.immuni.2004.09.001] [Cited by in Crossref: 117] [Cited by in F6Publishing: 106] [Article Influence: 6.9] [Reference Citation Analysis]
211 Hayden MS, West AP, Ghosh S. NF-kappaB and the immune response. Oncogene. 2006;25:6758-6780. [PMID: 17072327 DOI: 10.1038/sj.onc.1209943] [Cited by in Crossref: 769] [Cited by in F6Publishing: 722] [Article Influence: 51.3] [Reference Citation Analysis]
212 Kiyama K, Kawabata D, Hosono Y, Kitagori K, Yukawa N, Yoshifuji H, Omura K, Fujii T, Mimori T. Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance. Arthritis Res Ther. 2012;14:R86. [PMID: 22531553 DOI: 10.1186/ar3810] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
213 Aradottir Pind AA, Molina Estupiñan JL, Magnusdottir GJ, Del Giudice G, Jonsdottir I, Bjarnarson SP. LT-K63 Enhances B Cell Activation and Survival Factors in Neonatal Mice That Translates Into Long-Lived Humoral Immunity. Front Immunol 2020;11:527310. [PMID: 33193301 DOI: 10.3389/fimmu.2020.527310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
214 Han SS, Yang SH, Choi M, Kim HR, Kim K, Lee S, Moon KC, Kim JY, Lee H, Lee JP, Jung JY, Kim S, Joo KW, Lim CS, Kang SW, Kim YS, Kim DK. The Role of TNF Superfamily Member 13 in the Progression of IgA Nephropathy. J Am Soc Nephrol 2016;27:3430-9. [PMID: 27068226 DOI: 10.1681/ASN.2015060677] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
215 Yazdani R, Hakemi MG, Sherkat R, Homayouni V, Farahani R. Genetic defects and the role of helper T-cells in the pathogenesis of common variable immunodeficiency. Adv Biomed Res 2014;3:2. [PMID: 24600593 DOI: 10.4103/2277-9175.124627] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
216 Masoumi M, Bashiri H, Khorramdelazad H, Barzaman K, Hashemi N, Sereshki HA, Sahebkar A, Karami J. Destructive Roles of Fibroblast-like Synoviocytes in Chronic Inflammation and Joint Damage in Rheumatoid Arthritis. Inflammation 2021;44:466-79. [PMID: 33113036 DOI: 10.1007/s10753-020-01371-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
217 Parameswaran R, David HB, Sharabi A, Zinger H, Mozes E. B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus. Clinical Immunology 2009;131:223-32. [DOI: 10.1016/j.clim.2008.12.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
218 Felföldi B, Bódi I, Minkó K, Benyeda Z, Nagy N, Magyar A, Oláh I. Infection of bursal disease virus abrogates the extracellular glycoprotein in the follicular medulla. Poult Sci 2021;100:101000. [PMID: 33690054 DOI: 10.1016/j.psj.2021.01.023] [Reference Citation Analysis]
219 Nakamura N, Hase H, Sakurai D, Yoshida S, Abe M, Tsukada N, Takizawa J, Aoki S, Kojima M, Nakamura S, Kobata T. Expression of BAFF-R (BR 3) in normal and neoplastic lymphoid tissues characterized with a newly developed monoclonal antibody. Virchows Arch 2005;447:53-60. [PMID: 16025281 DOI: 10.1007/s00428-005-1275-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
220 Guan Z, Shui Y, Zhang S. Two related ligands of the TNF family, BAFF and APRIL, in rabbit: Molecular cloning, 3D modeling, and tissue distribution. Cytokine 2007;39:192-200. [DOI: 10.1016/j.cyto.2007.07.190] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
221 Xu G, Shen XJ, Pu J, Chu SP, Wang XD, Wu XH, Sun CJ, Zhang X, Zhu BL, Ju SQ. BLyS expression and JNK activation may form a feedback loop to promote survival and proliferation of multiple myeloma cells. Cytokine 2012;60:505-13. [PMID: 22850273 DOI: 10.1016/j.cyto.2012.06.317] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
222 O'Neill DW, Adams S, Bhardwaj N. Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood. 2004;104:2235-2246. [PMID: 15231572 DOI: 10.1182/blood-2003-12-4392] [Cited by in Crossref: 241] [Cited by in F6Publishing: 209] [Article Influence: 14.2] [Reference Citation Analysis]
223 Lenert A, Niewold TB, Lenert P. Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date. Drug Des Devel Ther 2017;11:747-57. [PMID: 28331294 DOI: 10.2147/DDDT.S114552] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
224 Cho W, Choe J. Prostaglandin E2 stimulates COX-2 expression via mitogen-activated protein kinase p38 but not ERK in human follicular dendritic cell-like cells. BMC Immunol 2020;21:20. [PMID: 32303181 DOI: 10.1186/s12865-020-00347-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
225 Moreaux J, Veyrune JL, De Vos J, Klein B. APRIL is overexpressed in cancer: link with tumor progression. BMC Cancer 2009;9:83. [PMID: 19291294 DOI: 10.1186/1471-2407-9-83] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
226 Palamarchuk A, Efanov A, Nazaryan N, Santanam U, Alder H, Rassenti L, Kipps T, Croce CM, Pekarsky Y. 13q14 deletions in CLL involve cooperating tumor suppressors. Blood 2010;115:3916-22. [DOI: 10.1182/blood-2009-10-249367] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 6.3] [Reference Citation Analysis]
227 Keller CW, Schmidt J, Lünemann JD. Immune and myodegenerative pathomechanisms in inclusion body myositis. Ann Clin Transl Neurol 2017;4:422-45. [PMID: 28589170 DOI: 10.1002/acn3.419] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
228 Pulendran B, Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell. 2006;124:849-863. [PMID: 16497593 DOI: 10.1016/j.cell.2006.02.019] [Cited by in Crossref: 447] [Cited by in F6Publishing: 401] [Article Influence: 29.8] [Reference Citation Analysis]
229 Kuwano Y, Fujimoto M, Watanabe R, Ishiura N, Nakashima H, Ohno Y, Yano S, Yazawa N, Okochi H, Tamaki K. Serum BAFF and APRIL levels in patients with alopecia areata. Journal of Dermatological Science 2008;50:236-9. [DOI: 10.1016/j.jdermsci.2008.01.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
230 Brink R. Regulation of B cell self-tolerance by BAFF. Semin Immunol 2006;18:276-83. [PMID: 16916609 DOI: 10.1016/j.smim.2006.04.003] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
231 Newell KA, Asare A, Sanz I, Wei C, Rosenberg A, Gao Z, Kanaparthi S, Asare S, Lim N, Stahly M. Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients. Am J Transplant. 2015;15:2908-2920. [PMID: 26461968 DOI: 10.1111/ajt.13480] [Cited by in Crossref: 67] [Cited by in F6Publishing: 52] [Article Influence: 11.2] [Reference Citation Analysis]
232 Tschen SI, Stohlman SA, Ramakrishna C, Hinton DR, Atkinson RD, Bergmann CC. CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS. Eur J Immunol 2006;36:603-12. [PMID: 16437540 DOI: 10.1002/eji.200535123] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 3.7] [Reference Citation Analysis]
233 Garcia-Carmona Y, Cols M, Ting AT, Radigan L, Yuk FJ, Zhang L, Cerutti A, Cunningham-Rundles C. Differential induction of plasma cells by isoforms of human TACI. Blood 2015;125:1749-58. [PMID: 25631768 DOI: 10.1182/blood-2014-05-575845] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
234 Daridon C, Burmester GR, Dörner T. Anticytokine therapy impacting on B cells in autoimmune diseases. Curr Opin Rheumatol 2009;21:205-10. [PMID: 19346949 DOI: 10.1097/BOR.0b013e32832a0760] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
235 Goenka R, Scholz JL, Sindhava VJ, Cancro MP. New roles for the BLyS/BAFF family in antigen-experienced B cell niches. Cytokine Growth Factor Rev 2014;25:107-13. [PMID: 24507939 DOI: 10.1016/j.cytogfr.2014.01.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
236 Sadanand S, Tomayko MM. B Cell Biology. In: Gaspari AA, Tyring SK, Kaplan DH, editors. Clinical and Basic Immunodermatology. Cham: Springer International Publishing; 2017. pp. 97-119. [DOI: 10.1007/978-3-319-29785-9_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
237 Kampa M, Notas G, Stathopoulos EN, Tsapis A, Castanas E. The TNFSF Members APRIL and BAFF and Their Receptors TACI, BCMA, and BAFFR in Oncology, With a Special Focus in Breast Cancer. Front Oncol 2020;10:827. [PMID: 32612943 DOI: 10.3389/fonc.2020.00827] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
238 Moisini I, Davidson A. BAFF: a local and systemic target in autoimmune diseases. Clin Exp Immunol. 2009;158:155-163. [PMID: 19737141 DOI: 10.1111/j.1365-2249.2009.04007.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 101] [Article Influence: 9.4] [Reference Citation Analysis]
239 Wei S, Sun Y, Sha H. Therapeutic targeting of BET protein BRD4 delays murine lupus. International Immunopharmacology 2015;29:314-9. [DOI: 10.1016/j.intimp.2015.10.036] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
240 Randall KL. Generating humoral immune memory following infection or vaccination. Expert Review of Vaccines 2014;9:1083-93. [DOI: 10.1586/erv.10.103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
241 Kim H, Moon E. Reactive Oxygen Species-Induced Expression of B cell Activating Factor (BAFF) Is Independent of Toll-like Receptor 4 and Myeloid Differentiation Primary Response Gene 88. Biomolecules and Therapeutics 2009;17:144-50. [DOI: 10.4062/biomolther.2009.17.2.144] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
242 Xu W, Joo H, Clayton S, Dullaers M, Herve MC, Blankenship D, De La Morena MT, Balderas R, Picard C, Casanova JL, Pascual V, Oh S, Banchereau J. Macrophages induce differentiation of plasma cells through CXCL10/IP-10. J Exp Med 2012;209:1813-23, S1-2. [PMID: 22987802 DOI: 10.1084/jem.20112142] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 5.7] [Reference Citation Analysis]
243 Kohno T, Daa T, Otani H, Shimokawa I, Yokoyama S, Matsuyama T. Aberrant expression of BAFF receptor, a member of the tumor necrosis factor receptor family, in malignant cells of nonhematopoietic origins. Genes to Cells 2008;13:1061-73. [DOI: 10.1111/j.1365-2443.2008.01227.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
244 Hamdy HS, Abdelkader NA, Mansour A, Allam EH, El-Wakiel HM, Elshenawy D. B cell non-Hodgkin's lymphoma in chronic hepatitis C virus patients: An interesting relationship. Indian J Gastroenterol 2015;34:127-34. [PMID: 25917521 DOI: 10.1007/s12664-015-0549-4] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
245 Wu H, Han D, Jiang Z, Zhao D, Liu M, Xu X, Liu X, Yang L, Ji X, Wang M, Zhang S. Equine adipose-derived stem cell (ASC) expresses BAFF and its receptors, which may be associated with the differentiation process of ASC towards adipocyte. International Immunopharmacology 2014;18:365-72. [DOI: 10.1016/j.intimp.2013.12.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
246 Okano H, Shiraki K, Yamanaka Y, Inoue H, Kawakita T, Saitou Y, Yamaguchi Y, Enokimura N, Ito K, Yamamoto N, Sugimoto K, Murata K, Nakano T. Functional expression of a proliferation-related ligand in hepatocellular carcinoma and its implications for neovascularization. World J Gastroenterol 2005;11:4650-4. [PMID: 16094704 DOI: 10.3748/wjg.v11.i30.4650] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
247 Treml JF, Hao Y, Stadanlick JE, Cancro MP. The BLyS family: toward a molecular understanding of B cell homeostasis. Cell Biochem Biophys 2009;53:1-16. [PMID: 19034695 DOI: 10.1007/s12013-008-9036-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 5.0] [Reference Citation Analysis]
248 Youinou P, Pers JO. The late news on baff in autoimmune diseases. Autoimmun Rev 2010;9:804-6. [PMID: 20656068 DOI: 10.1016/j.autrev.2010.06.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
249 Ohmatsu H, Sugaya M, Miyagaki T, Suga H, Fujita H, Asano Y, Tada Y, Kadono T, Sato S. BAFF levels are increased in lesional skin and sera in patients with cutaneous T-cell lymphoma: BAFF levels are increased in patients with CTCL. British Journal of Dermatology 2012;167:359-67. [DOI: 10.1111/j.1365-2133.2012.10998.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
250 Singh N, Kumar B, Aluri V, Lenert P. Interfering with baffled B cells at the lupus tollway: Promises, successes, and failed expectations. J Allergy Clin Immunol 2016;137:1325-33. [PMID: 26953155 DOI: 10.1016/j.jaci.2015.12.1326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
251 Meng F, Sun Y, Xu T. Comparative genomic of the BAFF and BAFF-like genes and immune response to bacteria of miiuy croaker (Miichthys miiuy). Fish Shellfish Immunol 2015;43:191-9. [PMID: 25542380 DOI: 10.1016/j.fsi.2014.12.022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
252 Liang Y, Xian Z, Fu D, Liu S, Yao Y, Jin Y, Gao C, Shen L, Shi G, He J. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome. Front Immunol 2021;12:673658. [PMID: 34012457 DOI: 10.3389/fimmu.2021.673658] [Reference Citation Analysis]
253 Varfolomeev E, Kischkel F, Martin F, Seshasayee D, Wang H, Lawrence D, Olsson C, Tom L, Erickson S, French D, Schow P, Grewal IS, Ashkenazi A. APRIL-deficient mice have normal immune system development. Mol Cell Biol 2004;24:997-1006. [PMID: 14729948 DOI: 10.1128/MCB.24.3.997-1006.2004] [Cited by in Crossref: 131] [Cited by in F6Publishing: 40] [Article Influence: 7.7] [Reference Citation Analysis]
254 Cuesta-Mateos C, Alcaraz-Serna A, Somovilla-Crespo B, Muñoz-Calleja C. Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets. Front Immunol 2017;8:1936. [PMID: 29387053 DOI: 10.3389/fimmu.2017.01936] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
255 Ng LG, Mackay CR, Mackay F. The BAFF/APRIL system: life beyond B lymphocytes. Mol Immunol 2005;42:763-72. [PMID: 15829264 DOI: 10.1016/j.molimm.2004.06.041] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 6.4] [Reference Citation Analysis]
256 Crowley JE, Scholz JL, Quinn WJ 3rd, Stadanlick JE, Treml JF, Treml LS, Hao Y, Goenka R, O'Neill PJ, Matthews AH, Parsons RF, Cancro MP. Homeostatic control of B lymphocyte subsets. Immunol Res 2008;42:75-83. [PMID: 18668213 DOI: 10.1007/s12026-008-8036-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
257 Woodland RT, Fox CJ, Schmidt MR, Hammerman PS, Opferman JT, Korsmeyer SJ, Hilbert DM, Thompson CB. Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 2008;111:750-60. [PMID: 17942753 DOI: 10.1182/blood-2007-03-077222] [Cited by in Crossref: 136] [Cited by in F6Publishing: 125] [Article Influence: 9.7] [Reference Citation Analysis]
258 Vijay A, Gertz MA. Waldenström macroglobulinemia. Blood 2007;109:5096-103. [DOI: 10.1182/blood-2006-11-055012] [Cited by in Crossref: 134] [Cited by in F6Publishing: 83] [Article Influence: 9.6] [Reference Citation Analysis]
259 Cope AP, Feldmann M. Emerging approaches for the therapy of autoimmune and chronic inflammatory disease. Current Opinion in Immunology 2004;16:780-6. [DOI: 10.1016/j.coi.2004.09.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
260 Warnatz K, Salzer U, Rizzi M, Fischer B, Gutenberger S, Böhm J, Kienzler AK, Pan-Hammarström Q, Hammarström L, Rakhmanov M, Schlesier M, Grimbacher B, Peter HH, Eibel H. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 2009;106:13945-50. [PMID: 19666484 DOI: 10.1073/pnas.0903543106] [Cited by in Crossref: 250] [Cited by in F6Publishing: 218] [Article Influence: 20.8] [Reference Citation Analysis]
261 Suryani S, Tangye SG. Therapeutic implications of advances in our understanding of transitional B-cell development in humans. Expert Review of Clinical Immunology 2014;6:765-75. [DOI: 10.1586/eci.10.55] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
262 Han SS, Yang SH, Jo HA, Oh YJ, Park M, Kim JY, Lee H, Lee JP, Lee SH, Joo KW, Lim CS, Kim YS, Kim DK. BAFF and APRIL expression as an autoimmune signature of membranous nephropathy. Oncotarget 2018;9:3292-302. [PMID: 29423047 DOI: 10.18632/oncotarget.23232] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
263 Warnatz K, Schlesier M. Flowcytometric phenotyping of common variable immunodeficiency. Cytometry B Clin Cytom 2008;74:261-71. [PMID: 18561200 DOI: 10.1002/cyto.b.20432] [Cited by in Crossref: 95] [Cited by in F6Publishing: 86] [Article Influence: 7.3] [Reference Citation Analysis]
264 Morrison MD, Reiley W, Zhang M, Sun SC. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway. J Biol Chem 2005;280:10018-24. [PMID: 15644327 DOI: 10.1074/jbc.M413634200] [Cited by in Crossref: 87] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
265 Yang M, Sun L, Wang S, Ko KH, Xu H, Zheng BJ, Cao X, Lu L. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J Immunol. 2010;184:3321-3325. [PMID: 20208006 DOI: 10.4049/jimmunol.0902551] [Cited by in Crossref: 179] [Cited by in F6Publishing: 164] [Article Influence: 16.3] [Reference Citation Analysis]
266 Lin WY, Wang HH, Chen YW, Lin CF, Fan HC, Lee YY. Gene Modified CAR-T Cellular Therapy for Hematologic Malignancies. Int J Mol Sci 2020;21:E8655. [PMID: 33212810 DOI: 10.3390/ijms21228655] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
267 Ninan MJ, Wadhwa PD, Gupta P. Prognostication of diffuse large B-cell lymphoma in the rituximab era. Leukemia & Lymphoma 2011;52:360-73. [DOI: 10.3109/10428194.2010.543716] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
268 Do KH, Choi HJ, Kim J, Park S, Kim K, Moon Y. SOCS3 Regulates BAFF in Human Enterocytes under Ribosomal Stress. J I 2013;190:6501-10. [DOI: 10.4049/jimmunol.1203004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
269 Gauld SB, Merrell KT, Cambier JC. Silencing of autoreactive B cells by anergy: a fresh perspective. Curr Opin Immunol 2006;18:292-7. [PMID: 16616480 DOI: 10.1016/j.coi.2006.03.015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
270 Uzzan M, Colombel JF, Cerutti A, Treton X, Mehandru S. B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases. Dig Dis Sci 2016;61:3407-24. [PMID: 27655102 DOI: 10.1007/s10620-016-4317-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
271 Zeng Q, Qin S, Zhang H, Liu B, Qin J, Wang X, Zhang R, Liu C, Dong X, Zhang S, Huang S, Chen L. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells. J Cell Physiol 2018;233:516-29. [PMID: 28300280 DOI: 10.1002/jcp.25913] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
272 Jain A, Ma CA, Lopez-Granados E, Means G, Brady W, Orange JS, Liu S, Holland S, Derry JM. Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation. J Clin Invest 2004;114:1593-602. [PMID: 15578091 DOI: 10.1172/JCI21345] [Cited by in Crossref: 62] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
273 Yang L, Zhou L, Zong X, Cao X, Ji X, Gu W, Zhang S. Characterization of the molecular structure, expression and bioactivity of the TNFSF13B (BAFF) gene of the South African clawed frog, Xenopus laevis. Int Immunopharmacol 2013;15:478-87. [PMID: 23428910 DOI: 10.1016/j.intimp.2013.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
274 Oden F, Marino SF, Brand J, Scheu S, Kriegel C, Olal D, Takvorian A, Westermann J, Yilmaz B, Hinz M, Daumke O, Höpken UE, Müller G, Lipp M. Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma. Mol Oncol 2015;9:1348-58. [PMID: 25953704 DOI: 10.1016/j.molonc.2015.03.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
275 Enzler T, Bonizzi G, Silverman GJ, Otero DC, Widhopf GF, Anzelon-Mills A, Rickert RC, Karin M. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity 2006;25:403-15. [PMID: 16973390 DOI: 10.1016/j.immuni.2006.07.010] [Cited by in Crossref: 129] [Cited by in F6Publishing: 124] [Article Influence: 8.6] [Reference Citation Analysis]
276 Nguyen DC, Joyner CJ, Sanz I, Lee FE. Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells. Front Immunol 2019;10:2138. [PMID: 31572364 DOI: 10.3389/fimmu.2019.02138] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
277 Leishman AJ, Sims GP, Sleeman M, Braddock M. Emerging small molecule and biological therapeutic approaches for the treatment of autoimmunity. Expert Opin Investig Drugs 2011;20:23-39. [PMID: 21118058 DOI: 10.1517/13543784.2011.540569] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
278 Puri P, Sanyal AJ. The BAFFling problem of B cell-activating factor in nonalcoholic fatty liver disease. Hepatol Int 2013;7:309-12. [PMID: 26201767 DOI: 10.1007/s12072-012-9418-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
279 Ma X, Che N, Gu Z, Huang J, Wang D, Liang J, Hou Y, Gilkeson G, Lu L, Sun L. Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation. Cell Transplant 2013;22:2279-90. [PMID: 23127285 DOI: 10.3727/096368912X658692] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
280 Netti GS, Infante B, Spadaccino F, Godeas G, Corallo MG, Prisciandaro C, Croce L, Rotondi M, Gesualdo L, Stallone G, Grandaliano G, Ranieri E. Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous Nephropathy. J Immunol Res 2019;2019:8483650. [PMID: 31781684 DOI: 10.1155/2019/8483650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
281 Georgakis GV, Younes A. Cytokines and lymphomas. Cancer Treat Res 2005;126:69-102. [PMID: 16209063 DOI: 10.1007/0-387-24361-5_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
282 Xu L, He Y, Ding Y, Liu GE, Zhang H, Cheng HH, Taylor RL Jr, Song J. Genetic assessment of inbred chicken lines indicates genomic signatures of resistance to Marek's disease. J Anim Sci Biotechnol 2018;9:65. [PMID: 30221000 DOI: 10.1186/s40104-018-0281-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
283 Vilas-Boas A, Morais SA, Isenberg DA. Belimumab in systemic lupus erythematosus. RMD Open 2015;1:e000011. [PMID: 26509047 DOI: 10.1136/rmdopen-2014-000011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
284 Hayden MS, Ghosh S. NF-κB in immunobiology. Cell Res 2011;21:223-44. [PMID: 21243012 DOI: 10.1038/cr.2011.13] [Cited by in Crossref: 460] [Cited by in F6Publishing: 423] [Article Influence: 46.0] [Reference Citation Analysis]
285 Kanno Y, Sakurai D, Hase H, Kojima H, Kobata T. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-κB signaling. Journal of Receptors and Signal Transduction 2010;30:121-32. [DOI: 10.3109/10799891003634509] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
286 Zhao L, Wang Q, Zhou B, Zhang L, Zhu H. The Role of Immune Cells in the Pathogenesis of Idiopathic Inflammatory Myopathies. Aging Dis 2021;12:247-60. [PMID: 33532139 DOI: 10.14336/AD.2020.0410] [Reference Citation Analysis]
287 González-Serna D, Carmona EG, Ortego-Centeno N, Simeón CP, Solans R, Hernández-Rodríguez J, Tolosa C, Castañeda S, Narváez J, Martinez-Valle F, Witte T, Neumann T, Holle J, Beretta L, Boiardi L, Emmi G, Cimmino MA, Vaglio A, Herrick AL, Denton CP, Salvarani C, Cid MC, Morgan AW, Fonseca C, González-Gay MA, Martín J, Márquez A; European GCA Consortium., European Scleroderma Group. A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility. PLoS One 2018;13:e0209343. [PMID: 30586461 DOI: 10.1371/journal.pone.0209343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
288 Sundin M, Remberger M, Lindqvist H, Omazic B, Sundberg B, Uzunel M, Winiarski J. Hypogammaglobulinemia in children after allogeneic hematopoietic stem cell transplantation: A cytokine mediated immunoglobulin isotype class switch arrest?: Hypogammaglobulinemia in Pediatric HSCT. Pediatr Blood Cancer 2015;62:890-6. [DOI: 10.1002/pbc.25409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
289 Oliver PM, Wang M, Zhu Y, White J, Kappler J, Marrack P. Loss of Bim allows precursor B cell survival but not precursor B cell differentiation in the absence of interleukin 7. J Exp Med 2004;200:1179-87. [PMID: 15520248 DOI: 10.1084/jem.20041129] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
290 Park JH, Resnick ES, Cunningham-Rundles C. Perspectives on common variable immune deficiency. Ann N Y Acad Sci 2011;1246:41-9. [PMID: 22236429 DOI: 10.1111/j.1749-6632.2011.06338.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
291 Baker D, Jacobs BM, Gnanapavan S, Schmierer K, Giovannoni G. Plasma cell and B cell-targeted treatments for use in advanced multiple sclerosis. Mult Scler Relat Disord 2019;35:19-25. [PMID: 31279232 DOI: 10.1016/j.msard.2019.06.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
292 Sakurai D, Kanno Y, Hase H, Kojima H, Okumura K, Kobata T. TACI attenuates antibody production costimulated by BAFF-R and CD40. Eur J Immunol 2007;37:110-8. [PMID: 17154264 DOI: 10.1002/eji.200636623] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
293 McClements M, Williams S, Ball C, Bristow A, Wadhwa M, Meager A. A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cells. J Immunol Methods 2008;337:63-70. [PMID: 18625509 DOI: 10.1016/j.jim.2008.05.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
294 Sutherland AP, Ng LG, Fletcher CA, Shum B, Newton RA, Grey ST, Rolph MS, Mackay F, Mackay CR. BAFF augments certain Th1-associated inflammatory responses. J Immunol 2005;174:5537-44. [PMID: 15843552 DOI: 10.4049/jimmunol.174.9.5537] [Cited by in Crossref: 111] [Cited by in F6Publishing: 102] [Article Influence: 6.9] [Reference Citation Analysis]
295 He B, Qiao X, Cerutti A. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol 2004;173:4479-91. [PMID: 15383579 DOI: 10.4049/jimmunol.173.7.4479] [Cited by in Crossref: 216] [Cited by in F6Publishing: 205] [Article Influence: 12.7] [Reference Citation Analysis]
296 Ehrenberg PK, Shangguan S, Issac B, Alter G, Geretz A, Izumi T, Bryant C, Eller MA, Wegmann F, Apps R, Creegan M, Bolton DL, Sekaly RP, Robb ML, Gramzinski RA, Pau MG, Schuitemaker H, Barouch DH, Michael NL, Thomas R. A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials. Sci Transl Med 2019;11:eaaw4236. [PMID: 31462510 DOI: 10.1126/scitranslmed.aaw4236] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
297 Jabara HH, Lee JJ, Janssen E, Ullas S, Liadaki K, Garibyan L, Benson H, Sannikova T, Bram R, Hammarstrom L, Cruz AC, Siegel R, Manis J, Malley R, Geha RS. Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice. J Allergy Clin Immunol 2017;139:1293-1301.e4. [PMID: 27609654 DOI: 10.1016/j.jaci.2016.07.028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
298 Ramanujam M, Wang X, Huang W, Schiffer L, Grimaldi C, Akkerman A, Diamond B, Madaio MP, Davidson A. Mechanism of Action of Transmembrane Activator and Calcium Modulator Ligand Interactor-Ig in Murine Systemic Lupus Erythematosus. J Immunol 2004;173:3524-34. [DOI: 10.4049/jimmunol.173.5.3524] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 5.7] [Reference Citation Analysis]
299 Marks DJ, Seymour CR, Sewell GW, Rahman FZ, Smith AM, McCartney SA, Bloom SL. Inflammatory bowel diseases in patients with adaptive and complement immunodeficiency disorders. Inflamm Bowel Dis 2010;16:1984-92. [PMID: 20848466 DOI: 10.1002/ibd.21280] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
300 Ren W, Pang S, You F, Zhou L, Zhang S. The first BAFF gene cloned from the cartilaginous fish. Fish Shellfish Immunol 2011;31:1088-96. [PMID: 21959037 DOI: 10.1016/j.fsi.2011.09.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
301 Kong S, Thiruppathi M, Qiu Q, Lin Z, Dong H, Chini EN, Prabhakar BS, Fang D. DBC1 is a suppressor of B cell activation by negatively regulating alternative NF-κB transcriptional activity. J Immunol 2014;193:5515-24. [PMID: 25362179 DOI: 10.4049/jimmunol.1401798] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
302 Alsaleh G, Messer L, Semaan N, Boulanger N, Gottenberg JE, Sibilia J, Wachsmann D. BAFF synthesis by rheumatoid synoviocytes is positively controlled by alpha5beta1 integrin stimulation and is negatively regulated by tumor necrosis factor alpha and Toll-like receptor ligands. Arthritis Rheum. 2007;56:3202-3214. [PMID: 17907168 DOI: 10.1002/art.22915] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
303 Prieto-Peña D, Genre F, Remuzgo-Martínez S, Pulito-Cueto V, Atienza-Mateo B, Llorca J, Sevilla-Pérez B, Ortego-Centeno N, Lera-Gómez L, Leonardo MT, Peñalba A, Narváez J, Martín-Penagos L, Rodrigo E, Miranda-Filloy JA, Caminal-Montero L, Collado P, Pérez JS, de Argila D, Rubio E, Luque ML, Blanco-Madrigal JM, Galíndez-Agirregoikoa E, Gualillo O, Martín J, Castañeda S, Blanco R, González-Gay MA, López-Mejías R. BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis. Sci Rep 2021;11:11510. [PMID: 34075170 DOI: 10.1038/s41598-021-91055-z] [Reference Citation Analysis]
304 Anuradha R, Munisankar S, Bhootra Y, Dolla C, Kumaran P, Nutman TB, Babu S. Modulation of Mycobacterium tuberculosis-specific humoral immune responses is associated with Strongyloides stercoralis co-infection. PLoS Negl Trop Dis 2017;11:e0005569. [PMID: 28459817 DOI: 10.1371/journal.pntd.0005569] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
305 Gavin AL, Aït-Azzouzene D, Ware CF, Nemazee D. DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF. J Biol Chem 2003;278:38220-8. [PMID: 12867412 DOI: 10.1074/jbc.M306852200] [Cited by in Crossref: 82] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
306 Li X. Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling. Cytokine 2008;41:105-13. [PMID: 18061473 DOI: 10.1016/j.cyto.2007.09.015] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
307 Patke A, Mecklenbräuker I, Erdjument-Bromage H, Tempst P, Tarakhovsky A. BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism. J Exp Med 2006;203:2551-62. [PMID: 17060474 DOI: 10.1084/jem.20060990] [Cited by in Crossref: 146] [Cited by in F6Publishing: 142] [Article Influence: 9.7] [Reference Citation Analysis]
308 Melchers F. B cell development and its deregulation to transformed states at the pre-B cell receptor-expressing pre-BII cell stage. Curr Top Microbiol Immunol 2005;294:1-17. [PMID: 16323425 DOI: 10.1007/3-540-29933-5_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
309 Sutherland AP, Mackay F, Mackay CR. Targeting BAFF: Immunomodulation for autoimmune diseases and lymphomas. Pharmacology & Therapeutics 2006;112:774-86. [DOI: 10.1016/j.pharmthera.2006.06.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
310 Gaudin E, Rosado M, Agenes F, Mclean A, Freitas AA. B-cell homeostasis, competition, resources, and positive selection by self-antigens. Immunol Rev 2004;197:102-15. [DOI: 10.1111/j.0105-2896.2004.0095.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
311 Adams S, O’Neill DW, Bhardwaj N. Recent advances in dendritic cell biology. J Clin Immunol. 2005;25:177-188. [PMID: 16118915 DOI: 10.1007/s10875-005-4086-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 29] [Article Influence: 1.1] [Reference Citation Analysis]
312 Kern C, Cornuel JF, Billard C, Tang R, Rouillard D, Stenou V, Defrance T, Ajchenbaum-Cymbalista F, Simonin PY, Feldblum S, Kolb JP. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 2004;103:679-88. [PMID: 14504101 DOI: 10.1182/blood-2003-02-0540] [Cited by in Crossref: 223] [Cited by in F6Publishing: 197] [Article Influence: 12.4] [Reference Citation Analysis]
313 Das S, Sutoh Y, Hirano M, Han Q, Li J, Cooper MD, Herrin BR. Characterization of Lamprey BAFF-like Gene: Evolutionary Implications. J Immunol 2016;197:2695-703. [PMID: 27543613 DOI: 10.4049/jimmunol.1600799] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
314 Xia Y, Campbell SR, Broder A, Herlitz L, Abadi M, Wu P, Michaelson JS, Burkly LC, Putterman C. Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis. Clin Immunol 2012;145:108-21. [PMID: 22982296 DOI: 10.1016/j.clim.2012.08.008] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 7.8] [Reference Citation Analysis]
315 Huang Y, Getahun A, Heiser RA, Detanico TO, Aviszus K, Kirchenbaum GA, Casper TL, Huang C, Aydintug MK, Carding SR, Ikuta K, Huang H, Wysocki LJ, Cambier JC, O'Brien RL, Born WK. γδ T Cells Shape Preimmune Peripheral B Cell Populations. J Immunol 2016;196:217-31. [PMID: 26582947 DOI: 10.4049/jimmunol.1501064] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
316 Gabay C, Krenn V, Bosshard C, Seemayer CA, Chizzolini C, Huard B. Synovial tissues concentrate secreted APRIL. Arthritis Res Ther 2009;11:R144. [PMID: 19788740 DOI: 10.1186/ar2817] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
317 Devarapu SK, Lorenz G, Kulkarni OP, Anders HJ, Mulay SR. Cellular and Molecular Mechanisms of Autoimmunity and Lupus Nephritis. Int Rev Cell Mol Biol 2017;332:43-154. [PMID: 28526137 DOI: 10.1016/bs.ircmb.2016.12.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
318 Zhu X, Shi Y, Peng J, Guo C, Shan N, Qin P, Ji X, Hou M. The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia. Blood 2009;114:5362-7. [DOI: 10.1182/blood-2009-05-217513] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
319 Ji F, Chen R, Liu B, Zhang X, Han J, Wang H, Shen G, Tao J. BAFF induces spleen CD4+ T cell proliferation by down-regulating phosphorylation of FOXO3A and activates cyclin D2 and D3 expression. Biochemical and Biophysical Research Communications 2012;425:854-8. [DOI: 10.1016/j.bbrc.2012.08.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
320 Thomas MD, Kremer CS, Ravichandran KS, Rajewsky K, Bender TP. c-Myb Is Critical for B Cell Development and Maintenance of Follicular B Cells. Immunity 2005;23:275-86. [DOI: 10.1016/j.immuni.2005.08.005] [Cited by in Crossref: 127] [Cited by in F6Publishing: 126] [Article Influence: 7.9] [Reference Citation Analysis]
321 Pelanda R, Torres RM. Central B-cell tolerance: where selection begins. Cold Spring Harb Perspect Biol 2012;4:a007146. [PMID: 22378602 DOI: 10.1101/cshperspect.a007146] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 7.1] [Reference Citation Analysis]
322 Yuan D. Interactions Between NK Cells and B Lymphocytes. Elsevier; 2004. pp. 1-42. [DOI: 10.1016/s0065-2776(04)84001-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
323 Lynall ME, Kigar SL, Lehmann ML, DePuyt AE, Tuong ZK, Listwak SJ, Elkahloun AG, Bullmore ET, Herkenham M, Clatworthy MR. B-cells are abnormal in psychosocial stress and regulate meningeal myeloid cell activation. Brain Behav Immun 2021:S0889-1591(21)00292-0. [PMID: 34371135 DOI: 10.1016/j.bbi.2021.08.002] [Reference Citation Analysis]
324 Parameswaran R, Yu M, Lyu MA, Lim M, Rosenblum MG, Groffen J, Heisterkamp N. Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin. Leukemia 2012;26:1786-96. [PMID: 22373785 DOI: 10.1038/leu.2012.54] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
325 Wada K, Maeda K, Tajima K, Kato T, Kobata T, Yamakawa M. Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas. Histopathology 2009;54:221-32. [DOI: 10.1111/j.1365-2559.2008.03203.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
326 Garibyan L, Lobito AA, Siegel RM, Call ME, Wucherpfennig KW, Geha RS. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID). J Clin Invest 2007;117:1550-7. [PMID: 17492055 DOI: 10.1172/JCI31023] [Cited by in Crossref: 75] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
327 Rathmell JC. B-cell homeostasis: digital survival or analog growth? Immunol Rev 2004;197:116-28. [DOI: 10.1111/j.0105-2896.2004.0096.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
328 Roullet MR, Bagg A. Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed–Sternberg cell. Expert Review of Molecular Diagnostics 2014;7:805-20. [DOI: 10.1586/14737159.7.6.805] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
329 Lewis DB, Wilson CB. Developmental Immunology and Role of Host Defenses in Fetal and Neonatal Susceptibility to Infection. Infectious Diseases of the Fetus and Newborn Infant. Elsevier; 2006. pp. 87-210. [DOI: 10.1016/b0-72-160537-0/50006-2] [Cited by in Crossref: 18] [Article Influence: 1.2] [Reference Citation Analysis]
330 den Hartog G, van Osch TLJ, Vos M, Meijer B, Savelkoul HFJ, van Neerven RJJ, Brugman S. BAFF augments IgA2 and IL-10 production by TLR7/8 stimulated total peripheral blood B cells. Eur J Immunol 2018;48:283-92. [PMID: 28921509 DOI: 10.1002/eji.201646861] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
331 Lee JW, Lee J, Um SH, Moon EY. Synovial cell death is regulated by TNF-α-induced expression of B-cell activating factor through an ERK-dependent increase in hypoxia-inducible factor-1α. Cell Death Dis 2017;8:e2727. [PMID: 28383556 DOI: 10.1038/cddis.2017.26] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
332 Lee JJ, Ozcan E, Rauter I, Geha RS. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency. Curr Opin Allergy Clin Immunol 2008;8:520-6. [PMID: 18978466 DOI: 10.1097/ACI.0b013e3283141200] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
333 Elgueta R, de Vries VC, Noelle RJ. The immortality of humoral immunity. Immunol Rev 2010;236:139-50. [PMID: 20636814 DOI: 10.1111/j.1600-065X.2010.00924.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 45] [Article Influence: 6.6] [Reference Citation Analysis]
334 Schmidt MR, Appel MC, Giassi LJ, Greiner DL, Shultz LD, Woodland RT. Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice. PLoS One 2008;3:e3192. [PMID: 18784835 DOI: 10.1371/journal.pone.0003192] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
335 Kathamuthu GR, Moideen K, Banurekha VV, Nair D, Sridhar R, Baskaran D, Babu S. Altered circulating levels of B cell growth factors and their modulation upon anti-tuberculosis treatment in pulmonary tuberculosis and tuberculous lymphadenitis. PLoS One 2018;13:e0207404. [PMID: 30427928 DOI: 10.1371/journal.pone.0207404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
336 Gümüş P, Nizam N, Lappin DF, Buduneli N. Saliva and serum levels of B-cell activating factors and tumor necrosis factor-α in patients with periodontitis. J Periodontol 2014;85:270-80. [PMID: 23701482 DOI: 10.1902/jop.2013.130117] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
337 Holl TM, Haynes BF, Kelsoe G. Stromal cell independent B cell development in vitro: generation and recovery of autoreactive clones. J Immunol Methods 2010;354:53-67. [PMID: 20109461 DOI: 10.1016/j.jim.2010.01.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
338 Randolph GJ, Jakubzick C, Qu C. Antigen presentation by monocytes and monocyte-derived cells. Curr Opin Immunol 2008;20:52-60. [PMID: 18160272 DOI: 10.1016/j.coi.2007.10.010] [Cited by in Crossref: 140] [Cited by in F6Publishing: 134] [Article Influence: 10.0] [Reference Citation Analysis]
339 Pallikkuth S, Pilakka Kanthikeel S, Silva SY, Fischl M, Pahwa R, Pahwa S. Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy. J Immunol 2011;186:6173-81. [PMID: 21531891 DOI: 10.4049/jimmunol.1100264] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 5.8] [Reference Citation Analysis]
340 Looney RJ. B Cell-Targeted Therapies for Systemic Lupus Erythematosus: An Update on Clinical Trial Data. Drugs 2010;70:529-40. [DOI: 10.2165/11535420-000000000-00000] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
341 Chaoul N, Burelout C, Peruchon S, van Buu BN, Laurent P, Proust A, Raphael M, Garraud O, Le Grand R, Prevot S, Richard Y. Default in plasma and intestinal IgA responses during acute infection by simian immunodeficiency virus. Retrovirology 2012;9:43. [PMID: 22632376 DOI: 10.1186/1742-4690-9-43] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
342 Hancz A, Hérincs Z, Neer Z, Sármay G, Koncz G. Integration of signals mediated by B-cell receptor, B-cell activating factor of the tumor necrosis factor family (BAFF) and Fas (CD95). Immunol Lett 2008;116:211-7. [PMID: 18243342 DOI: 10.1016/j.imlet.2007.12.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
343 Youinou P, Pers JO. Disturbance of cytokine networks in Sjögren’s syndrome. Arthritis Res Ther. 2011;13:227. [PMID: 21745420 DOI: 10.1186/ar3348] [Cited by in Crossref: 77] [Cited by in F6Publishing: 70] [Article Influence: 7.7] [Reference Citation Analysis]
344 Lee GH, Oh JM, Kim HS, Yoon WK, Yi KY, Yang Y, Han SH, Lee S, Moon EY. KR33426, [2-(2,5-dichlorophenyl)-5-methyloxazol-4yl]carbonylguanidine, is a novel compound to be effective on mouse systemic lupus erythematosus. Eur J Pharmacol 2011;668:459-66. [PMID: 21827747 DOI: 10.1016/j.ejphar.2011.07.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
345 Hajishengallis G, Korostoff JM. Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later. Periodontol 2000 2017;75:116-51. [PMID: 28758305 DOI: 10.1111/prd.12181] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 24.0] [Reference Citation Analysis]
346 Lahiri A, Pochard P, Le Pottier L, Tobón GJ, Bendaoud B, Youinou P, Pers J. The complexity of the BAFF TNF-family members: Implications for autoimmunity. Journal of Autoimmunity 2012;39:189-98. [DOI: 10.1016/j.jaut.2012.05.009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
347 Wang H, Clarke SH. Positive selection focuses the VH12 B-cell repertoire towards a single B1 specificity with survival function. Immunol Rev 2004;197:51-9. [DOI: 10.1111/j.0105-2896.2004.0098.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
348 Benson MJ, Dillon SR, Castigli E, Geha RS, Xu S, Lam KP, Noelle RJ. Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J Immunol 2008;180:3655-9. [PMID: 18322170 DOI: 10.4049/jimmunol.180.6.3655] [Cited by in Crossref: 311] [Cited by in F6Publishing: 284] [Article Influence: 23.9] [Reference Citation Analysis]
349 Ai H, Shen Y, Min C, Pang S, Zhang J, Zhang S, Zhao Z. Molecular structure, expression and bioactivity characterization of TNF13B (BAFF) gene in mefugu, Takifugu obscurus. Fish Shellfish Immunol 2011;30:1265-74. [PMID: 21463693 DOI: 10.1016/j.fsi.2011.03.020] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
350 Bruins WSC, Zweegman S, Mutis T, van de Donk NWCJ. Targeted Therapy With Immunoconjugates for Multiple Myeloma. Front Immunol 2020;11:1155. [PMID: 32636838 DOI: 10.3389/fimmu.2020.01155] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 14.0] [Reference Citation Analysis]
351 Eslami M, Meinl E, Eibel H, Willen L, Donzé O, Distl O, Schneider H, Speiser DE, Tsiantoulas D, Yalkinoglu Ö, Samy E, Schneider P. BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid. Front Cell Dev Biol 2020;8:577662. [PMID: 33240880 DOI: 10.3389/fcell.2020.577662] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
352 Morais SA, Vilas-Boas A, Isenberg DA. B-cell survival factors in autoimmune rheumatic disorders. Ther Adv Musculoskelet Dis 2015;7:122-51. [PMID: 26288664 DOI: 10.1177/1759720X15586782] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
353 Li ZW, Dalton WS. Tumor microenvironment and drug resistance in hematologic malignancies. Blood Rev 2006;20:333-42. [PMID: 16920238 DOI: 10.1016/j.blre.2005.08.003] [Cited by in Crossref: 99] [Cited by in F6Publishing: 85] [Article Influence: 6.6] [Reference Citation Analysis]
354 Hymowitz SG, Patel DR, Wallweber HJ, Runyon S, Yan M, Yin J, Shriver SK, Gordon NC, Pan B, Skelton NJ, Kelley RF, Starovasnik MA. Structures of APRIL-Receptor Complexes. Journal of Biological Chemistry 2005;280:7218-27. [DOI: 10.1074/jbc.m411714200] [Cited by in Crossref: 120] [Cited by in F6Publishing: 50] [Article Influence: 7.5] [Reference Citation Analysis]
355 Bassyouni IH, Azab NA, El-dakrony EM, Fawzi MM, Ghanoum R, Bassyouni RH. Elevated serum levels of a proliferation-inducing ligand in patients with systemic sclerosis: Possible association with myositis? Joint Bone Spine 2011;78:56-61. [DOI: 10.1016/j.jbspin.2010.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
356 Nagel A, Hertl M, Eming R. B-cell-directed therapy for inflammatory skin diseases. J Invest Dermatol 2009;129:289-301. [PMID: 19148218 DOI: 10.1038/jid.2008.192] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
357 Yu S, Wang Y, Liu Y, Mo W, Song H, Yu M. Expression and purification of APRIL by auto-induction. Protein Expr Purif 2009;68:49-53. [PMID: 19545632 DOI: 10.1016/j.pep.2009.06.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
358 Chung JB, Silverman M, Monroe JG. Transitional B cells: step by step towards immune competence. Trends Immunol 2003;24:343-9. [PMID: 12810111 DOI: 10.1016/s1471-4906(03)00119-4] [Cited by in Crossref: 144] [Cited by in F6Publishing: 71] [Article Influence: 8.0] [Reference Citation Analysis]
359 Mhawech-Fauceglia P, Kaya G, Sauter G, McKee T, Donze O, Schwaller J, Huard B. The source of APRIL up-regulation in human solid tumor lesions. J Leukoc Biol 2006;80:697-704. [PMID: 16793914 DOI: 10.1189/jlb.1105655] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
360 Nakajima K, Itoh K, Nagatani K, Okawa-Takatsuji M, Fujii T, Kuroki H, Katsuragawa Y, Aotsuka S, Mimori A. Expression of BAFF and BAFF-R in the synovial tissue of patients with rheumatoid arthritis. Scand J Rheumatol 2007;36:365-72. [PMID: 17963166 DOI: 10.1080/03009740701286615] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
361 Agrawal N, Chiang L, Rifkin IR. Lupus Nephritis. Seminars in Nephrology 2006;26:95-104. [DOI: 10.1016/j.semnephrol.2005.09.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
362 Wedgwood A, Younes A. Targeting Lymphoma Cells and Their Microenvironment with Novel Antibodies. Clinical Lymphoma and Myeloma 2006;7:S33-40. [DOI: 10.3816/clm.2006.s.006] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
363 Schuster A, Jung B, Hofbauer J, Kühne L, Zecher D, Banas B, Bergler T. B-cell activating factor BAFF reflects patients' immunological risk profile after kidney transplantation. Transpl Immunol 2017;45:35-41. [PMID: 28867309 DOI: 10.1016/j.trim.2017.08.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
364 van der Burg M, van Zelm MC, Driessen GJ, van Dongen JJ. New frontiers of primary antibody deficiencies. Cell Mol Life Sci 2012;69:59-73. [PMID: 22042269 DOI: 10.1007/s00018-011-0836-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
365 Ellyard J, Avery D, Mackay C, Tangye S. Contribution of stromal cells to the migration, function and retention of plasma cells in human spleen: potential roles of CXCL12, IL-6 and CD54. Eur J Immunol 2005;35:699-708. [DOI: 10.1002/eji.200425442] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
366 Lee SM, Kim EJ, Suk K, Lee WH. BAFF and APRIL induce inflammatory activation of THP-1 cells through interaction with their conventional receptors and activation of MAPK and NF-κB. Inflamm Res 2011;60:807-15. [PMID: 21505913 DOI: 10.1007/s00011-011-0336-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
367 Balatti V, Pekarky Y, Rizzotto L, Croce CM. miR deregulation in CLL. Adv Exp Med Biol 2013;792:309-25. [PMID: 24014303 DOI: 10.1007/978-1-4614-8051-8_14] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
368 Fletcher CA, Groom JR, Woehl B, Leung H, Mackay C, Mackay F. Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice. J Autoimmun 2011;36:125-34. [PMID: 21216131 DOI: 10.1016/j.jaut.2010.12.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
369 Gianchecchi E, Delfino DV, Fierabracci A. NK cells in autoimmune diseases: Linking innate and adaptive immune responses. Autoimmunity Reviews 2018;17:142-54. [DOI: 10.1016/j.autrev.2017.11.018] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 21.3] [Reference Citation Analysis]
370 Benson MJ, Elgueta R, Noelle RJ. B cell survival: an unexpected mechanism of lymphocyte vitality. Immunol Cell Biol 2008;86:485-6. [PMID: 18490932 DOI: 10.1038/icb.2008.35] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
371 Zarkhin V, Chalasani G, Sarwal MM. The yin and yang of B cells in graft rejection and tolerance. Transplant Rev (Orlando) 2010;24:67-78. [PMID: 20149626 DOI: 10.1016/j.trre.2010.01.004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
372 Abo-Elfadl MT, Gamal-Eldeen AM, Ismail MF, Shahin NN. Silencing of the cytokine receptor TNFRSF13B: A new therapeutic target for triple-negative breast cancer. Cytokine 2020;125:154790. [PMID: 31400636 DOI: 10.1016/j.cyto.2019.154790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
373 Garcia-Carmona Y, Ting AT, Radigan L, Athuluri Divakar SK, Chavez J, Meffre E, Cerutti A, Cunningham-Rundles C. TACI Isoforms Regulate Ligand Binding and Receptor Function. Front Immunol 2018;9:2125. [PMID: 30333819 DOI: 10.3389/fimmu.2018.02125] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
374 Ponce R. Preclinical Support for Combination Therapy in the Treatment of Autoimmunity with Atacicept. Toxicol Pathol 2009;37:89-99. [DOI: 10.1177/0192623308329477] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
375 Bergqvist P, Gärdby E, Stensson A, Bemark M, Lycke NY. Gut IgA class switch recombination in the absence of CD40 does not occur in the lamina propria and is independent of germinal centers. J Immunol 2006;177:7772-83. [PMID: 17114448 DOI: 10.4049/jimmunol.177.11.7772] [Cited by in Crossref: 104] [Cited by in F6Publishing: 94] [Article Influence: 7.4] [Reference Citation Analysis]
376 Xu H, He X, Liu Q, Shi D, Chen Y, Zhu Y, Zhang X. Abnormal high expression of B-cell activating factor belonging to the TNF superfamily (BAFF) associated with long-term outcome in kidney transplant recipients. Transplant Proc 2009;41:1552-6. [PMID: 19545677 DOI: 10.1016/j.transproceed.2008.10.024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
377 Chu VT, Enghard P, Riemekasten G, Berek C. In vitro and in vivo activation induces BAFF and APRIL expression in B cells. J Immunol 2007;179:5947-57. [PMID: 17947668 DOI: 10.4049/jimmunol.179.9.5947] [Cited by in Crossref: 93] [Cited by in F6Publishing: 79] [Article Influence: 6.6] [Reference Citation Analysis]
378 Pavelek Z, Novotny M, Soucek O, Krejsek J, Sobisek L, Sejkorova I, Masopust J, Kuca K, Valis M, Klimova B, Stourac P. Multiple sclerosis and immune system biomarkers: Novel comparison in glatiramer acetate and interferon beta-1a-treated patient groups. Mult Scler Relat Disord 2021;53:103082. [PMID: 34166982 DOI: 10.1016/j.msard.2021.103082] [Reference Citation Analysis]
379 Schleimer RP, Kato A, Peters A, Conley D, Kim J, Liu MC, Harris KE, Kuperman DA, Chandra R, Favoreto S Jr, Avila PC, Grammer LC, Kern RC. Epithelium, inflammation, and immunity in the upper airways of humans: studies in chronic rhinosinusitis. Proc Am Thorac Soc 2009;6:288-94. [PMID: 19387032 DOI: 10.1513/pats.200808-088RM] [Cited by in Crossref: 72] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
380 Thapa M, Tedesco D, Gumber S, Elrod EJ, Han JH, Kitchens WH, Magliocca JF, Adams AB, Grakoui A. Blockade of BAFF Reshapes the Hepatic B Cell Receptor Repertoire and Attenuates Autoantibody Production in Cholestatic Liver Disease. J Immunol 2020;204:3117-28. [PMID: 32332110 DOI: 10.4049/jimmunol.1900391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
381 Shi C, Shenkar R, Zeineddine HA, Girard R, Fam MD, Austin C, Moore T, Lightle R, Zhang L, Wu M, Cao Y, Gunel M, Louvi A, Rorrer A, Gallione C, Marchuk DA, Awad IA. B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models. J Neuroimmune Pharmacol 2016;11:369-77. [PMID: 27086141 DOI: 10.1007/s11481-016-9670-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
382 Ding W, Ju S, Jiang S, Zhu L, Wang Y, Wang H. Reduced APRIL Expression Induces Cellular Senescence via a HSPG-Dependent Pathway. Pathol Oncol Res 2009;15:693-701. [DOI: 10.1007/s12253-009-9172-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
383 Nishio M, Endo T, Tsukada N, Ohata J, Kitada S, Reed JC, Zvaifler NJ, Kipps TJ. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood 2005;106:1012-20. [PMID: 15860672 DOI: 10.1182/blood-2004-03-0889] [Cited by in Crossref: 200] [Cited by in F6Publishing: 186] [Article Influence: 12.5] [Reference Citation Analysis]
384 Debnath I, Roundy KM, Weis JJ, Weis JH. Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23. Mol Immunol 2007;44:2388-99. [PMID: 17140663 DOI: 10.1016/j.molimm.2006.10.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
385 Cerutti A, Chen K. Role of BAFF and APRIL in Antibody Production and Diversification. In: Cancro MP, editor. BLyS Ligands and Receptors. Totowa: Humana Press; 2010. pp. 65-92. [DOI: 10.1007/978-1-60327-013-7_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
386 Ittah M, Miceli-Richard C, Eric Gottenberg J, Lavie F, Lazure T, Ba N, Sellam J, Lepajolec C, Mariette X. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome. Arthritis Res Ther 2006;8:R51. [PMID: 16507175 DOI: 10.1186/ar1912] [Cited by in Crossref: 182] [Cited by in F6Publishing: 164] [Article Influence: 12.1] [Reference Citation Analysis]
387 Ingold K, Zumsteg A, Tardivel A, Huard B, Steiner QG, Cachero TG, Qiang F, Gorelik L, Kalled SL, Acha-Orbea H, Rennert PD, Tschopp J, Schneider P. Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med 2005;201:1375-83. [PMID: 15851487 DOI: 10.1084/jem.20042309] [Cited by in Crossref: 250] [Cited by in F6Publishing: 224] [Article Influence: 15.6] [Reference Citation Analysis]
388 Cozine CL, Wolniak KL, Waldschmidt TJ. The primary germinal center response in mice. Curr Opin Immunol 2005;17:298-302. [PMID: 15886120 DOI: 10.1016/j.coi.2005.04.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
389 Engelhard VH, Rodriguez AB, Mauldin IS, Woods AN, Peske JD, Slingluff CL Jr. Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity. J Immunol 2018;200:432-42. [PMID: 29311385 DOI: 10.4049/jimmunol.1701269] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 23.0] [Reference Citation Analysis]
390 Dong W, Li X, Liu H, Zhu P. Infiltrations of plasma cells in synovium are highly associated with synovial fluid levels of APRIL in inflamed peripheral joints of rheumatoid arthritis. Rheumatol Int 2009;29:801-6. [PMID: 19037609 DOI: 10.1007/s00296-008-0773-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
391 du Plessis WJ, Walzl G, Loxton AG. B cells as multi-functional players during Mycobacterium tuberculosis infection and disease. Tuberculosis (Edinb) 2016;97:118-25. [PMID: 26611659 DOI: 10.1016/j.tube.2015.10.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
392 Steri M, Orrù V, Idda ML, Pitzalis M, Pala M, Zara I, Sidore C, Faà V, Floris M, Deiana M, Asunis I, Porcu E, Mulas A, Piras MG, Lobina M, Lai S, Marongiu M, Serra V, Marongiu M, Sole G, Busonero F, Maschio A, Cusano R, Cuccuru G, Deidda F, Poddie F, Farina G, Dei M, Virdis F, Olla S, Satta MA, Pani M, Delitala A, Cocco E, Frau J, Coghe G, Lorefice L, Fenu G, Ferrigno P, Ban M, Barizzone N, Leone M, Guerini FR, Piga M, Firinu D, Kockum I, Lima Bomfim I, Olsson T, Alfredsson L, Suarez A, Carreira PE, Castillo-Palma MJ, Marcus JH, Congia M, Angius A, Melis M, Gonzalez A, Alarcón Riquelme ME, da Silva BM, Marchini M, Danieli MG, Del Giacco S, Mathieu A, Pani A, Montgomery SB, Rosati G, Hillert J, Sawcer S, D'Alfonso S, Todd JA, Novembre J, Abecasis GR, Whalen MB, Marrosu MG, Meloni A, Sanna S, Gorospe M, Schlessinger D, Fiorillo E, Zoledziewska M, Cucca F. Overexpression of the Cytokine BAFF and Autoimmunity Risk. N Engl J Med 2017;376:1615-26. [PMID: 28445677 DOI: 10.1056/NEJMoa1610528] [Cited by in Crossref: 176] [Cited by in F6Publishing: 89] [Article Influence: 44.0] [Reference Citation Analysis]
393 Moreaux J, Hose D, Jourdan M, Reme T, Hundemer M, Moos M, Robert N, Moine P, De Vos J, Goldschmidt H, Klein B. TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines. Haematologica 2007;92:803-11. [PMID: 17550853 DOI: 10.3324/haematol.10574] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
394 Gyllemark P, Forsberg P, Ernerudh J, Henningsson AJ. Intrathecal Th17- and B cell-associated cytokine and chemokine responses in relation to clinical outcome in Lyme neuroborreliosis: a large retrospective study. J Neuroinflammation 2017;14:27. [PMID: 28148307 DOI: 10.1186/s12974-017-0789-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
395 Mhawech-fauceglia P, Allal A, Odunsi K, Andrews C, Herrmann F, Huard B. Role of the tumour necrosis family ligand APRIL in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas. European Journal of Cancer 2008;44:2097-100. [DOI: 10.1016/j.ejca.2008.07.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
396 Badr G, Borhis G, Lefevre EA, Chaoul N, Deshayes F, Dessirier V, Lapree G, Tsapis A, Richard Y. BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. Blood 2008;111:2744-54. [PMID: 18172003 DOI: 10.1182/blood-2007-03-081232] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 5.5] [Reference Citation Analysis]
397 Hendriks J, Planelles L, de Jong-Odding J, Hardenberg G, Pals ST, Hahne M, Spaargaren M, Medema JP. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ 2005;12:637-48. [PMID: 15846369 DOI: 10.1038/sj.cdd.4401647] [Cited by in Crossref: 154] [Cited by in F6Publishing: 134] [Article Influence: 9.6] [Reference Citation Analysis]
398 Nozaki Y. New Insights Into Novel Therapeutic Targets in ANCA-Associated Vasculitis. Front Immunol 2021;12:631055. [PMID: 33868250 DOI: 10.3389/fimmu.2021.631055] [Reference Citation Analysis]
399 Treml LS, Carlesso G, Hoek KL, Stadanlick JE, Kambayashi T, Bram RJ, Cancro MP, Khan WN. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J Immunol 2007;178:7531-9. [PMID: 17548587 DOI: 10.4049/jimmunol.178.12.7531] [Cited by in Crossref: 124] [Cited by in F6Publishing: 107] [Article Influence: 8.9] [Reference Citation Analysis]
400 Ding W, Wang J, Sun B, Ju S, Yuan H, Wang X, Wang Y, Wang H. APRIL knockdown suppresses migration and invasion of human colon carcinoma cells. Clinical Biochemistry 2009;42:1694-8. [DOI: 10.1016/j.clinbiochem.2009.06.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
401 Kaur K, Chowdhury S, Greenspan NS, Schreiber JR. Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates. Blood 2007;110:2948-54. [PMID: 17634409 DOI: 10.1182/blood-2007-01-069245] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 4.8] [Reference Citation Analysis]
402 Ohata J, Zvaifler NJ, Nishio M, Boyle DL, Kalled SL, Carson DA, Kipps TJ. Fibroblast-Like Synoviocytes of Mesenchymal Origin Express Functional B Cell-Activating Factor of the TNF Family in Response to Proinflammatory Cytokines. J Immunol 2005;174:864-70. [DOI: 10.4049/jimmunol.174.2.864] [Cited by in Crossref: 132] [Cited by in F6Publishing: 125] [Article Influence: 8.3] [Reference Citation Analysis]
403 Gilbert JA, Kalled SL, Moorhead J, Hess DM, Rennert P, Li Z, Khan MZ, Banga JP. Treatment of autoimmune hyperthyroidism in a murine model of Graves' disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology. Endocrinology 2006;147:4561-8. [PMID: 16794009 DOI: 10.1210/en.2006-0507] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
404 Koarada S, Tada Y, Sohma Y, Haruta Y, Suematsu R, Mitamura M, Inoue H, Ehara H, Tokoro Y, Ohta A. Autoantibody-producing RP105(-) B cells, from patients with systemic lupus erythematosus, showed more preferential expression of BCMA compared with BAFF-R than normal subjects. Rheumatology (Oxford). 2010;49:662-670. [PMID: 20097906 DOI: 10.1093/rheumatology/kep437] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
405 Youinou P, Taher TE, Pers J, Mageed RA, Renaudineau Y. B lymphocyte cytokines and rheumatic autoimmune disease. Arthritis Rheum 2009;60:1873-80. [DOI: 10.1002/art.24665] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
406 Moon EY, Lee YS, Choi WS, Lee MH. Toll-like receptor 4-mediated cAMP production up-regulates B-cell activating factor expression in Raw264.7 macrophages. Exp Cell Res 2011;317:2447-55. [PMID: 21782812 DOI: 10.1016/j.yexcr.2011.07.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
407 Zhang L, Radigan L, Salzer U, Behrens TW, Grimbacher B, Diaz G, Bussel J, Cunningham-Rundles C. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol 2007;120:1178-85. [PMID: 17983875 DOI: 10.1016/j.jaci.2007.10.001] [Cited by in Crossref: 132] [Cited by in F6Publishing: 109] [Article Influence: 10.2] [Reference Citation Analysis]
408 Lee GH, Lee MH, Yoon YD, Kang JS, Pyo S, Moon EY. Protein kinase C stimulates human B cell activating factor gene expression through reactive oxygen species-dependent c-Fos in THP-1 pro-monocytic cells. Cytokine 2012;59:115-23. [PMID: 22537850 DOI: 10.1016/j.cyto.2012.03.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
409 Yang M, Hase H, Legarda-Addison D, Varughese L, Seed B, Ting AT. B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells. J Immunol 2005;175:2814-24. [PMID: 16116167 DOI: 10.4049/jimmunol.175.5.2814] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 5.4] [Reference Citation Analysis]
410 Chu VT, Enghard P, Schürer S, Steinhauser G, Rudolph B, Riemekasten G, Berek C. Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus. Arthritis Rheum 2009;60:2083-93. [DOI: 10.1002/art.24628] [Cited by in Crossref: 79] [Cited by in F6Publishing: 70] [Article Influence: 6.6] [Reference Citation Analysis]
411 Zeng Q, Zhou Z, Qin S, Yao Y, Qin J, Zhang H, Zhang R, Xu C, Zhang S, Huang S, Chen L. Rapamycin inhibits B-cell activating factor (BAFF)-stimulated cell proliferation and survival by suppressing Ca2+-CaMKII-dependent PTEN/Akt-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells. Cell Calcium 2020;87:102171. [PMID: 32062191 DOI: 10.1016/j.ceca.2020.102171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
412 Groom J, Mackay F. B cells flying solo. Immunol Cell Biol 2008;86:40-6. [PMID: 18172443 DOI: 10.1038/sj.icb.7100142] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
413 Kryštůfková O, Hulejová H, Mann HF, Pecha O, Půtová I, Ekholm L, Lundberg IE, Vencovský J. Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis. Arthritis Res Ther 2018;20:158. [PMID: 30053824 DOI: 10.1186/s13075-018-1650-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
414 O’Connor BP, Raman VS, Erickson LD, Cook WJ, Weaver LK, Ahonen C, Lin LL, Mantchev GT, Bram RJ, Noelle RJ. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med. 2004;199:91-98. [PMID: 14707116 DOI: 10.1084/jem.20031330] [Cited by in Crossref: 668] [Cited by in F6Publishing: 600] [Article Influence: 39.3] [Reference Citation Analysis]
415 Arend WP, Gabay C. Cytokines in the rheumatic diseases. Rheumatic Disease Clinics of North America 2004;30:41-67. [DOI: 10.1016/s0889-857x(03)00115-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
416 Knight AK, Radigan L, Marron T, Langs A, Zhang L, Cunningham-Rundles C. High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency. Clin Immunol 2007;124:182-9. [PMID: 17556024 DOI: 10.1016/j.clim.2007.04.012] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 4.4] [Reference Citation Analysis]
417 Bloom D, Chang Z, Pauly K, Kwun J, Fechner J, Hayes C, Samaniego M, Knechtle S. BAFF is increased in renal transplant patients following treatment with alemtuzumab. Am J Transplant 2009;9:1835-45. [PMID: 19522878 DOI: 10.1111/j.1600-6143.2009.02710.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 69] [Article Influence: 6.7] [Reference Citation Analysis]
418 Bermejo DA, Amezcua-Vesely MC, Montes CL, Merino MC, Gehrau RC, Cejas H, Acosta-Rodríguez EV, Gruppi A. BAFF mediates splenic B cell response and antibody production in experimental Chagas disease. PLoS Negl Trop Dis 2010;4:e679. [PMID: 20454564 DOI: 10.1371/journal.pntd.0000679] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
419 Xu Z, Zhao B, Xiong H, Wei B, Wang Y. Serum BAFF and APRIL levels in patients with autoimmune hemolytic anemia and their clinical significance. Int J Hematol 2015;102:394-400. [DOI: 10.1007/s12185-015-1851-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
420 Ramanujam M, Davidson A. Targeting of the immune system in systemic lupus erythematosus. Expert Rev Mol Med 2008;10:e2. [PMID: 18205972 DOI: 10.1017/S1462399408000562] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
421 Kanagavelu S, Flores C, Hagiwara S, Ruiz J, Hyun J, Cho EE, Sun F, Romero L, Shih DQ, Fukata M. TIR-Domain-Containing Adapter-Inducing Interferon-β (TRIF) Regulates CXCR5+ T helper Cells in the Intestine. J Clin Cell Immunol 2016;7:458. [PMID: 27853628 DOI: 10.4172/2155-9899.1000458] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
422 Cohen S, Shachar I. Midkine as a regulator of B cell survival in health and disease. Br J Pharmacol 2014;171:888-95. [PMID: 24111754 DOI: 10.1111/bph.12419] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
423 Jacobi AM, Huang W, Wang T, Freimuth W, Sanz I, Furie R, Mackay M, Aranow C, Diamond B, Davidson A. Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum 2010;62:201-10. [PMID: 20039404 DOI: 10.1002/art.27189] [Cited by in Crossref: 139] [Cited by in F6Publishing: 125] [Article Influence: 12.6] [Reference Citation Analysis]
424 Ahuja A, Anderson SM, Khalil A, Shlomchik MJ. Maintenance of the plasma cell pool is independent of memory B cells. Proc Natl Acad Sci U S A 2008;105:4802-7. [PMID: 18339801 DOI: 10.1073/pnas.0800555105] [Cited by in Crossref: 118] [Cited by in F6Publishing: 108] [Article Influence: 9.1] [Reference Citation Analysis]
425 Ueda-Hayakawa I, Tanimura H, Osawa M, Iwasaka H, Ohe S, Yamazaki F, Mizuno K, Okamoto H. Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity. Rheumatology (Oxford) 2013;52:1658-66. [PMID: 23685362 DOI: 10.1093/rheumatology/ket186] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
426 Mackay F, Schneider P. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties. Cytokine Growth Factor Rev 2008;19:263-76. [PMID: 18514565 DOI: 10.1016/j.cytogfr.2008.04.006] [Cited by in Crossref: 95] [Cited by in F6Publishing: 91] [Article Influence: 7.3] [Reference Citation Analysis]
427 Fleming TJ, Sachdeva M, Delic M, Beltzer J, Wescott CR, Devlin M, Lander RC, Nixon AE, Roschke V, Hilbert DM, Sexton DJ. Discovery of high-affinity peptide binders to BLyS by phage display. J Mol Recognit 2005;18:94-102. [DOI: 10.1002/jmr.722] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
428 Ramanujam M, Wang X, Huang W, Liu Z, Schiffer L, Tao H, Frank D, Rice J, Diamond B, Yu KO, Porcelli S, Davidson A. Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J Clin Invest 2006;116:724-34. [PMID: 16485042 DOI: 10.1172/JCI26385] [Cited by in Crossref: 157] [Cited by in F6Publishing: 86] [Article Influence: 10.5] [Reference Citation Analysis]
429 Mackay F, Leung H. The role of the BAFF/APRIL system on T cell function. Semin Immunol 2006;18:284-9. [PMID: 16931039 DOI: 10.1016/j.smim.2006.04.005] [Cited by in Crossref: 124] [Cited by in F6Publishing: 102] [Article Influence: 8.3] [Reference Citation Analysis]
430 Moreaux J, Legouffe E, Jourdan E, Quittet P, Rème T, Lugagne C, Moine P, Rossi JF, Klein B, Tarte K. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 2004;103:3148-57. [PMID: 15070697 DOI: 10.1182/blood-2003-06-1984] [Cited by in Crossref: 362] [Cited by in F6Publishing: 314] [Article Influence: 20.1] [Reference Citation Analysis]
431 Pahl MV, Gollapudi S, Sepassi L, Gollapudi P, Elahimehr R, Vaziri ND. Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression. Nephrol Dial Transplant. 2010;25:205-212. [PMID: 19684120 DOI: 10.1093/ndt/gfp397] [Cited by in Crossref: 85] [Cited by in F6Publishing: 66] [Article Influence: 7.1] [Reference Citation Analysis]
432 Vicioso Y, Gram H, Beck R, Asthana A, Zhang K, Wong DP, Letterio J, Parameswaran R. Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia. Cancer Immunol Res 2019;7:1106-19. [PMID: 31138521 DOI: 10.1158/2326-6066.CIR-19-0058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
433 Berkowska MA, van der Burg M, van Dongen JJ, van Zelm MC. Checkpoints of B cell differentiation: visualizing Ig-centric processes. Ann N Y Acad Sci 2011;1246:11-25. [PMID: 22236426 DOI: 10.1111/j.1749-6632.2011.06278.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
434 Isik G, Sliepen K, van Montfort T, Sanders RW. Enhanced immunogenicity of HIV-1 envelope gp140 proteins fused to APRIL. PLoS One 2014;9:e107683. [PMID: 25247707 DOI: 10.1371/journal.pone.0107683] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
435 Baert L, Benkhoucha M, Popa N, Ahmed MC, Manfroi B, Boutonnat J, Sturm N, Raguenez G, Tessier M, Casez O, Marignier R, Ahmadi M, Broisat A, Ghezzi C, Rivat C, Sonrier C, Hahne M, Baeten D, Vives RR, Lortat-Jacob H, Marche PN, Schneider P, Lassmann HP, Boucraut J, Lalive PH, Huard B. A proliferation-inducing ligand-mediated anti-inflammatory response of astrocytes in multiple sclerosis. Ann Neurol 2019;85:406-20. [PMID: 30635946 DOI: 10.1002/ana.25415] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
436 Irure-Ventura J, San Segundo D, Rodrigo E, Merino D, Belmar-Vega L, Ruiz San Millán JC, Valero R, Benito A, López-Hoyos M. High Pretransplant BAFF Levels and B-cell Subset Polarized towards a Memory Phenotype as Predictive Biomarkers for Antibody-Mediated Rejection. Int J Mol Sci 2020;21:E779. [PMID: 31991734 DOI: 10.3390/ijms21030779] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
437 Pekarsky Y, Zanesi N, Croce CM. Molecular basis of CLL. Semin Cancer Biol 2010;20:370-6. [PMID: 20863894 DOI: 10.1016/j.semcancer.2010.09.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
438 Navarro-mendoza EP, Aguirre-valencia D, Posso-osorio I, Correa-forero SV, Torres-cutiva D, Loaiza D, Tobón GJ. Cytokine markers of B lymphocytes in minor salivary gland infiltrates in Sjögren's syndrome. Autoimmunity Reviews 2018;17:709-14. [DOI: 10.1016/j.autrev.2018.02.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
439 Aghamohmmadi A, Lougaris V, Plebani A, Miyawaki T, Durandy A, Hammarström L. Predominantly Antibody Deficiencies. In: Rezaei N, Aghamohammadi A, Notarangelo LD, editors. Primary Immunodeficiency Diseases. Berlin: Springer Berlin Heidelberg; 2008. pp. 97-130. [DOI: 10.1007/978-3-540-78936-9_3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
440 Choi JH, Zhong X, Zhang Z, Su L, McAlpine W, Misawa T, Liao TC, Zhan X, Russell J, Ludwig S, Li X, Tang M, Anderton P, Moresco EMY, Beutler B. Essential cell-extrinsic requirement for PDIA6 in lymphoid and myeloid development. J Exp Med 2020;217:e20190006. [PMID: 31985756 DOI: 10.1084/jem.20190006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
441 Haiat S, Billard C, Quiney C, Ajchenbaum-Cymbalista F, Kolb JP. Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia. Immunology 2006;118:281-92. [PMID: 16827889 DOI: 10.1111/j.1365-2567.2006.02377.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 4.8] [Reference Citation Analysis]
442 Migita K, Ilyassova B, Kovzel EF, Nersesov A, Abiru S, Maeda Y, Komori A, Ito M, Yano K, Yatsuhashi H. Serum BAFF and APRIL levels in patients with PBC. Clin Immunol. 2010;134:217-225. [PMID: 19840904 DOI: 10.1016/j.clim.2009.09.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
443 Haley SL, Tzvetkov EP, Lytle AG, Alugupalli KR, Plummer JR, McGettigan JP. APRIL:TACI axis is dispensable for the immune response to rabies vaccination. Antiviral Res 2017;144:130-7. [PMID: 28619678 DOI: 10.1016/j.antiviral.2017.06.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
444 Drumond MHF, Puhl LE, Duarte PM, Miranda TS, Clemente-Napimoga JT, Peruzzo DC, Martinez EF, Napimoga MH. Preliminary findings on the possible role of B-lymphocyte stimulator (BLyS) on diabetes-related periodontitis. Braz Oral Res 2020;34:e038. [PMID: 32374812 DOI: 10.1590/1807-3107bor-2020.vol34.0038] [Reference Citation Analysis]
445 Wong CK, Wong PTY, Tam LS, Li EK, Chen DP, Lam CWK. Elevated Production of B Cell Chemokine CXCL13 is Correlated with Systemic Lupus Erythematosus Disease Activity. J Clin Immunol 2010;30:45-52. [DOI: 10.1007/s10875-009-9325-5] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 7.4] [Reference Citation Analysis]
446 Lombardi T, Moll S, Youinou P, Pers J, Tzankov A, Gabay C, Santiago-raber M, Chizzolini C, Huard B. Absence of up-regulation for a proliferation-inducing ligand in Sjogren's sialadenitis lesions. Rheumatology 2011;50:1211-5. [DOI: 10.1093/rheumatology/ker016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
447 Nakayamada S, Tanaka Y. BAFF- and APRIL-targeted therapy in systemic autoimmune diseases. Inflamm Regen 2016;36:6. [PMID: 29259679 DOI: 10.1186/s41232-016-0015-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
448 Elsawa SF, Novak AJ, Grote DM, Ziesmer SC, Witzig TE, Kyle RA, Dillon SR, Harder B, Gross JA, Ansell SM. B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia. Blood 2006;107:2882-8. [PMID: 16304043 DOI: 10.1182/blood-2005-09-3552] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 4.3] [Reference Citation Analysis]
449 Badia R, Brufau MT, Guerrero-Zamora AM, Lizardo R, Dobrescu I, Martin-Venegas R, Ferrer R, Salmon H, Martínez P, Brufau J. β-Galactomannan and Saccharomyces cerevisiae var. boulardii modulate the immune response against Salmonella enterica serovar Typhimurium in porcine intestinal epithelial and dendritic cells. Clin Vaccine Immunol 2012;19:368-76. [PMID: 22301691 DOI: 10.1128/CVI.05532-11] [Cited by in Crossref: 33] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
450 Lee SM, Nam YP, Suk K, Lee WH. Immune receptor expressed on myeloid cells 1 (IREM-1) inhibits B cell activation factor (BAFF)-mediated inflammatory regulation of THP-1 cells through modulation of the activities of extracellular regulated kinase (ERK). Clin Exp Immunol 2010;161:504-11. [PMID: 20646006 DOI: 10.1111/j.1365-2249.2010.04211.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
451 Quinn WJ, Scholz JL, Cancro MP. Dwindling competition with constant demand: Can homeostatic adjustments explain age-associated changes in peripheral B cell selection? Seminars in Immunology 2005;17:362-9. [DOI: 10.1016/j.smim.2005.05.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
452 Hart M, Steel A, Clark SA, Moyle G, Nelson M, Henderson DC, Wilson R, Gotch F, Gazzard B, Kelleher P. Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. J Immunol. 2007;178:8212-8220. [PMID: 17548660 DOI: 10.4049/jimmunol.178.12.8212] [Cited by in Crossref: 114] [Cited by in F6Publishing: 121] [Article Influence: 8.1] [Reference Citation Analysis]
453 Li XC. The significance of non-T-cell pathways in graft rejection: implications for transplant tolerance. Transplantation. 2010;90:1043-1047. [PMID: 20686444 DOI: 10.1097/tp.0b013e3181efcfe9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
454 Dalla Palma B, Marchica V, Catarozzo MT, Giuliani N, Accardi F. Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma. J Clin Med 2020;9:E3022. [PMID: 32961764 DOI: 10.3390/jcm9093022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
455 Chauhan D, Anderson KC. Cytokines and Signal Transduction in Multiple Myeloma. In: Wiernik PH, Goldman JM, Dutcher JP, Kyle RA, editors. Neoplastic Diseases of the Blood. New York: Springer; 2013. pp. 535-46. [DOI: 10.1007/978-1-4614-3764-2_27] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
456 Rottman JB, Willis CR. Mouse Models of Systemic Lupus Erythematosus Reveal a Complex Pathogenesis. Vet Pathol 2010;47:664-76. [DOI: 10.1177/0300985810370005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
457 Khodadadi L, Cheng Q, Radbruch A, Hiepe F. The Maintenance of Memory Plasma Cells. Front Immunol 2019;10:721. [PMID: 31024553 DOI: 10.3389/fimmu.2019.00721] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 25.5] [Reference Citation Analysis]
458 Moir S, Malaspina A, Pickeral OK, Donoghue ET, Vasquez J, Miller NJ, Krishnan SR, Planta MA, Turney JF, Justement JS, Kottilil S, Dybul M, Mican JM, Kovacs C, Chun TW, Birse CE, Fauci AS. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J Exp Med 2004;200:587-99. [PMID: 15353552 DOI: 10.1084/jem.20032236] [Cited by in Crossref: 166] [Cited by in F6Publishing: 144] [Article Influence: 9.8] [Reference Citation Analysis]
459 Sotolongo J, Ruiz J, Fukata M. The role of innate immunity in the host defense against intestinal bacterial pathogens. Curr Infect Dis Rep 2012;14:15-23. [PMID: 22139594 DOI: 10.1007/s11908-011-0234-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
460 Mcheyzer-williams MG. B cells as effectors. Current Opinion in Immunology 2003;15:354-61. [DOI: 10.1016/s0952-7915(03)00046-3] [Cited by in Crossref: 87] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
461 Miao R, Lim VY, Kothapalli N, Ma Y, Fossati J, Zehentmeier S, Sun R, Pereira JP. Hematopoietic Stem Cell Niches and Signals Controlling Immune Cell Development and Maintenance of Immunological Memory. Front Immunol 2020;11:600127. [PMID: 33324418 DOI: 10.3389/fimmu.2020.600127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
462 Park YW, Pryshchep S, Seyler TM, Goronzy JJ, Weyand CM. B cells as a therapeutic target in autoimmune diseases. Expert Opinion on Therapeutic Targets 2005;9:431-45. [DOI: 10.1517/14728222.9.3.431] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
463 Youinou P, Devauchelle-Pensec V, Pers JO. Significance of B cells and B cell clonality in Sjögren's syndrome. Arthritis Rheum 2010;62:2605-10. [PMID: 20496425 DOI: 10.1002/art.27564] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
464 Vincent FB, Morand EF, Mackay F. BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus. Immunol Cell Biol 2012;90:293-303. [PMID: 22231653 DOI: 10.1038/icb.2011.111] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
465 Treml LS, Quinn WJ 3rd, Treml JF, Scholz JL, Cancro MP. Manipulating B cell homeostasis: a key component in the advancement of targeted strategies. Arch Immunol Ther Exp (Warsz) 2008;56:153-64. [PMID: 18512030 DOI: 10.1007/s00005-008-0017-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
466 Lin WY, Gong Q, Seshasayee D, Lin Z, Ou Q, Ye S, Suto E, Shu J, Lee WP, Lee CW, Fuh G, Leabman M, Iyer S, Howell K, Gelzleichter T, Beyer J, Danilenko D, Yeh S, DeForge LE, Ebens A, Thompson JS, Ambrose C, Balazs M, Starovasnik MA, Martin F. Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade. Blood 2007;110:3959-67. [PMID: 17687108 DOI: 10.1182/blood-2007-04-088088] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
467 De Vos J, Hose D, Rème T, Tarte K, Moreaux J, Mahtouk K, Jourdan M, Goldschmidt H, Rossi JF, Cremer FW, Klein B. Microarray-based understanding of normal and malignant plasma cells. Immunol Rev 2006;210:86-104. [PMID: 16623766 DOI: 10.1111/j.0105-2896.2006.00362.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
468 Dobosz E, Lorenz G, Ribeiro A, Würf V, Wadowska M, Kotlinowski J, Schmaderer C, Potempa J, Fu M, Koziel J, Lech M. Murine myeloid cell MCPIP1 suppresses autoimmunity by regulating B-cell expansion and differentiation. Dis Model Mech 2021;14:dmm047589. [PMID: 33737335 DOI: 10.1242/dmm.047589] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
469 Zapata JM, Lefebvre S, Reed JC. Targeting TRAFs for Therapeutic Intervention. In: Wu H, editor. TNF Receptor Associated Factors (TRAFs). New York: Springer; 2007. pp. 188-201. [DOI: 10.1007/978-0-387-70630-6_15] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
470 Kracker S, Gardes P, Mazerolles F, Durandy A. Immunoglobulin class switch recombination deficiencies. Clinical Immunology 2010;135:193-203. [DOI: 10.1016/j.clim.2010.01.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
471 Page EK, Dar WA, Knechtle SJ. Tolerogenic therapies in transplantation. Front Immunol 2012;3:198. [PMID: 22826708 DOI: 10.3389/fimmu.2012.00198] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 5.2] [Reference Citation Analysis]
472 Kyrtsonis MC, Sarris K, Koulieris E, Maltezas D, Nikolaou E, Angelopoulou MK, Bartzis V, Tzenou T, Dimou M, Siakandaris MP, Viniou NA, Sachanas S, Kalpadakis C, Sfikakis PP, Pangalis GA, Panayiotidis P. Serum soluble TACI, a BLyS receptor, is a powerful prognostic marker of outcome in chronic lymphocytic leukemia. Biomed Res Int 2014;2014:159632. [PMID: 25162001 DOI: 10.1155/2014/159632] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
473 Ding C. Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases. Expert Opinion on Biological Therapy 2008;8:1805-14. [DOI: 10.1517/14712598.8.11.1805] [Cited by in Crossref: 40] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
474 Gong Q, Ou Q, Ye S, Lee WP, Cornelius J, Diehl L, Lin WY, Hu Z, Lu Y, Chen Y, Wu Y, Meng YG, Gribling P, Lin Z, Nguyen K, Tran T, Zhang Y, Rosen H, Martin F, Chan AC. Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy. J Immunol 2005;174:817-26. [DOI: 10.4049/jimmunol.174.2.817] [Cited by in Crossref: 384] [Cited by in F6Publishing: 349] [Article Influence: 24.0] [Reference Citation Analysis]
475 Vossenkämper A, Lutalo PM, Spencer J. Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies. Clin Exp Immunol 2012;167:7-14. [PMID: 22132879 DOI: 10.1111/j.1365-2249.2011.04460.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
476 Jin X, Ding C. Belimumab--an anti-BLyS human monoclonal antibody for rheumatoid arthritis. Expert Opin Biol Ther 2013;13:315-22. [PMID: 23268610 DOI: 10.1517/14712598.2012.758248] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
477 Lee DSW, Rojas OL, Gommerman JL. B cell depletion therapies in autoimmune disease: advances and mechanistic insights. Nat Rev Drug Discov 2021;20:179-99. [PMID: 33324003 DOI: 10.1038/s41573-020-00092-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 19.0] [Reference Citation Analysis]
478 Mamara A, Germenis AE, Kompoti M, Palassopoulou M, Mandala E, Banti A, Giannakoulas N, Speletas M. TACI expression and signaling in chronic lymphocytic leukemia. J Immunol Res 2015;2015:478753. [PMID: 25950010 DOI: 10.1155/2015/478753] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
479 Cunningham-Rundles C. Human B cell defects in perspective. Immunol Res 2012;54:227-32. [PMID: 22477523 DOI: 10.1007/s12026-012-8318-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
480 Tarantino G, Marco VD, Petta S, Almasio PL, Barbaria F, Licata A, Bosco GL, Tripodo C, Stefano RD, Craxì A. Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection. Journal of Viral Hepatitis 2009;16:397-405. [DOI: 10.1111/j.1365-2893.2009.01093.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
481 Lee SM, Kim WJ, Suk K, Lee WH. Cell to Cell Interaction Can Activate Membrane-bound APRIL Which Are Expressed on Inflammatory Macrophages. Immune Netw 2010;10:173-80. [PMID: 21165246 DOI: 10.4110/in.2010.10.5.173] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
482 Arlehamn CL, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, Sette A, Vijayanand P, Peters B. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol 2014;193:2931-40. [PMID: 25092889 DOI: 10.4049/jimmunol.1401151] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 8.6] [Reference Citation Analysis]
483 Bischof D, Elsawa SF, Mantchev G, Yoon J, Michels GE, Nilson A, Sutor SL, Platt JL, Ansell SM, von Bulow G, Bram RJ. Selective activation of TACI by syndecan-2. Blood 2006;107:3235-42. [PMID: 16357320 DOI: 10.1182/blood-2005-01-0256] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
484 Chan VS, Tsang HH, Tam RC, Lu L, Lau CS. B-cell-targeted therapies in systemic lupus erythematosus. Cell Mol Immunol 2013;10:133-42. [PMID: 23455017 DOI: 10.1038/cmi.2012.64] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
485 Jones DD, Jones M, DeIulio GA, Racine R, MacNamara KC, Winslow GM. B cell activating factor inhibition impairs bacterial immunity by reducing T cell-independent IgM secretion. Infect Immun 2013;81:4490-7. [PMID: 24082070 DOI: 10.1128/IAI.00998-13] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
486 Hao Z, Duncan GS, Seagal J, Su YW, Hong C, Haight J, Chen NJ, Elia A, Wakeham A, Li WY, Liepa J, Wood GA, Casola S, Rajewsky K, Mak TW. Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. Immunity 2008;29:615-27. [PMID: 18835195 DOI: 10.1016/j.immuni.2008.07.016] [Cited by in Crossref: 148] [Cited by in F6Publishing: 131] [Article Influence: 11.4] [Reference Citation Analysis]
487 Roque R, Ponce R, Burleson F, Cabrit M, Broly H, Rogge M. Influenza virus host response of C57Bl/6 mice treated with TACI-Ig. Immunopharmacol Immunotoxicol 2006;28:13-32. [PMID: 16684665 DOI: 10.1080/08923970600623541] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
488 Issa GC, Leblebjian H, Roccaro AM, Ghobrial IM. New insights into the pathogenesis and treatment of Waldenstrom macroglobulinemia. Curr Opin Hematol 2011;18:260-5. [PMID: 21519243 DOI: 10.1097/MOH.0b013e3283474e5b] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
489 You F, Ren W, Hou H, Pei L, He Z. Molecular cloning, expression, bioinformatics analysis and bioactivity characterization of TNF13B (BAFF) gene in bat (Vespertilio superans Thomas). International Immunopharmacology 2012;12:433-40. [DOI: 10.1016/j.intimp.2011.12.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
490 Lee SM, Jeon ST, Suk K, Lee WH. Macrophages express membrane bound form of APRIL that can generate immunomodulatory signals. Immunology 2010;131:350-6. [PMID: 20518823 DOI: 10.1111/j.1365-2567.2010.03306.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
491 Soh KT, Tario JD, Wallace PK. Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry. Clin Lab Med. 2017;37:821-853. [PMID: 29128071 DOI: 10.1016/j.cll.2017.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
492 Gottenberg JE, Miceli-Richard C, Ducot B, Goupille P, Combe B, Mariette X. Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort. Arthritis Res Ther 2009;11:R114. [PMID: 19627580 DOI: 10.1186/ar2773] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
493 Sakurai D, Hase H, Kanno Y, Kojima H, Okumura K, Kobata T. TACI regulates IgA production by APRIL in collaboration with HSPG. Blood 2007;109:2961-7. [PMID: 17119122 DOI: 10.1182/blood-2006-08-041772] [Cited by in Crossref: 89] [Cited by in F6Publishing: 73] [Article Influence: 6.4] [Reference Citation Analysis]
494 Zhu X, Shi Y, Sun J, Shan N, Peng J, Guo C, Qin P, Hou M. High-Dose Dexamethasone Inhibits BAFF Expression in Patients with Immune Thrombocytopenia. J Clin Immunol 2009;29:603-10. [DOI: 10.1007/s10875-009-9303-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
495 Both T, Dalm VA, van Hagen PM, van Daele PL. Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment. Int J Med Sci 2017;14:191-200. [PMID: 28367079 DOI: 10.7150/ijms.17718] [Cited by in Crossref: 72] [Cited by in F6Publishing: 49] [Article Influence: 18.0] [Reference Citation Analysis]
496 Ferry H, Leung JC, Lewis G, Nijnik A, Silver K, Lambe T, Cornall RJ. B-cell tolerance. Transplantation 2006;81:308-15. [PMID: 16477212 DOI: 10.1097/01.tp.0000203830.79357.39] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
497 Montes C, Acosta-rodríguez E, Mucci J, Zuniga E, Campetella O, Gruppi A. ATrypanosoma cruzi antigen signals CD11b+ cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells. Eur J Immunol 2006;36:1474-85. [DOI: 10.1002/eji.200535537] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
498 Yarchoan M, Ho WJ, Mohan A, Shah Y, Vithayathil T, Leatherman J, Dennison L, Zaidi N, Ganguly S, Woolman S, Cruz K, Armstrong TD, Jaffee EM. Effects of B cell-activating factor on tumor immunity. JCI Insight 2020;5:136417. [PMID: 32434989 DOI: 10.1172/jci.insight.136417] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
499 Elsawa SF, Ansell SM. Cytokines in the microenvironment of Waldenström's macroglobulinemia. Clin Lymphoma Myeloma. 2009;9:43-45. [PMID: 19362970 DOI: 10.3816/CLM.2009.n.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
500 Sellner L, Fan F, Giesen N, Schubert ML, Goldschmidt H, Müller-Tidow C, Dreger P, Raab MS, Schmitt M. B-cell maturation antigen-specific chimeric antigen receptor T cells for multiple myeloma: Clinical experience and future perspectives. Int J Cancer 2020;147:2029-41. [PMID: 32270481 DOI: 10.1002/ijc.33002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
501 Peruchon S, Chaoul N, Burelout C, Delache B, Brochard P, Laurent P, Cognasse F, Prévot S, Garraud O, Le Grand R, Richard Y. Tissue-specific B-cell dysfunction and generalized memory B-cell loss during acute SIV infection. PLoS One 2009;4:e5966. [PMID: 19543531 DOI: 10.1371/journal.pone.0005966] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
502 Ramanujam M, Davidson A. The current status of targeting BAFF/BLyS for autoimmune diseases. Arthritis Res Ther 2004;6:197-202. [PMID: 15380033 DOI: 10.1186/ar1222] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
503 Ferrer G, Hodgson K, Pereira A, Juan M, Elena M, Colomer D, Roué G, Aymerich M, Baumann T, Montserrat E, Moreno C. Combined analysis of levels of serum B-cell activating factor and a proliferation-inducing ligand as predictor of disease progression in patients with chronic lymphocytic leukemia. Leuk Lymphoma 2011;52:2064-8. [PMID: 21707303 DOI: 10.3109/10428194.2011.591008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
504 Kim SJ, Won JH. B cell homeostasis and the development of chronic graft-versus-host disease: implications for B cell-depleting therapy. Leuk Lymphoma 2012;53:19-25. [PMID: 21740304 DOI: 10.3109/10428194.2011.603448] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
505 Shah HB, Joshi SK, Rampuria P, Devera TS, Lang GA, Stohl W, Lang ML. BAFF- and APRIL-dependent maintenance of antibody titers after immunization with T-dependent antigen and CD1d-binding ligand. J Immunol 2013;191:1154-63. [PMID: 23797666 DOI: 10.4049/jimmunol.1300263] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
506 Yamazaki T, Kurosaki T. Contribution of BCAP to maintenance of mature B cells through c-Rel. Nat Immunol 2003;4:780-6. [DOI: 10.1038/ni949] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
507 Gregoriou S, Papafragkaki D, Kontochristopoulos G, Rallis E, Kalogeromitros D, Rigopoulos D. Cytokines and other mediators in alopecia areata. Mediators Inflamm 2010;2010:928030. [PMID: 20300578 DOI: 10.1155/2010/928030] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
508 Lesley R, Xu Y, Kalled SL, Hess DM, Schwab SR, Shu HB, Cyster JG. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 2004;20:441-53. [PMID: 15084273 DOI: 10.1016/s1074-7613(04)00079-2] [Cited by in Crossref: 423] [Cited by in F6Publishing: 223] [Article Influence: 24.9] [Reference Citation Analysis]
509 Adams S, O'Neill DW, Bhardwaj N. Recent advances in dendritic cell biology. J Clin Immunol 2005;25:87-98. [PMID: 15821885 DOI: 10.1007/s10875-005-2814-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
510 Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. Common variable immunodeficiency: a new look at an old disease. Lancet 2008;372:489-502. [PMID: 18692715 DOI: 10.1016/S0140-6736(08)61199-X] [Cited by in Crossref: 212] [Cited by in F6Publishing: 68] [Article Influence: 16.3] [Reference Citation Analysis]
511 Genovese MC. Biologic therapies in clinical development for the treatment of rheumatoid arthritis. J Clin Rheumatol 2005;11:S45-54. [PMID: 16357750 DOI: 10.1097/01.rhu.0000166625.65114.5f] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
512 Maeda S, Ohno K, Fujiwara-Igarashi A, Tomiyasu H, Fujino Y, Tsujimoto H. Methylation of TNFRSF13B and TNFRSF13C in duodenal mucosa in canine inflammatory bowel disease and its association with decreased mucosal IgA expression. Vet Immunol Immunopathol 2014;160:97-106. [PMID: 24814046 DOI: 10.1016/j.vetimm.2014.04.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
513 Davidson A. The rationale for BAFF inhibition in systemic lupus erythematosus. Curr Rheumatol Rep 2012;14:295-302. [PMID: 22535567 DOI: 10.1007/s11926-012-0258-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
514 Lin Z, Dan-Rong Y, Xiao-Qing T, Hao W, Hong-Lian G, Xian-Tao K, Ren-Qian Z, Jiyu L. Preliminary clinical measurement of the expression of B-cell activating factor in Chinese systemic lupus erythematosus patients. J Clin Lab Anal 2007;21:183-7. [PMID: 17506477 DOI: 10.1002/jcla.20161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
515 Burger JA, Quiroga MP, Hartmann E, Bürkle A, Wierda WG, Keating MJ, Rosenwald A. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation. Blood 2009;113:3050-8. [PMID: 19074730 DOI: 10.1182/blood-2008-07-170415] [Cited by in Crossref: 216] [Cited by in F6Publishing: 205] [Article Influence: 16.6] [Reference Citation Analysis]
516 Cassani B, Poliani PL, Marrella V, Schena F, Sauer AV, Ravanini M, Strina D, Busse CE, Regenass S, Wardemann H, Martini A, Facchetti F, van der Burg M, Rolink AG, Vezzoni P, Grassi F, Traggiai E, Villa A. Homeostatic expansion of autoreactive immunoglobulin-secreting cells in the Rag2 mouse model of Omenn syndrome. Journal of Experimental Medicine 2010;207:1525-40. [DOI: 10.1084/jem.20091928] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
517 Jeurissen A, Ceuppens JL, Bossuyt X. T lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens. Immunology 2004;111:1-7. [PMID: 14678191 DOI: 10.1111/j.1365-2567.2004.01775.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
518 Guadagnoli M, Kimberley FC, Phan U, Cameron K, Vink PM, Rodermond H, Eldering E, Kater AP, van Eenennaam H, Medema JP. Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas. Blood 2011;117:6856-65. [PMID: 21543761 DOI: 10.1182/blood-2011-01-330852] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
519 Guan Z, Yao W, Ye J, Dan W, Shen J, Zhang S. The construction and characterization of a bifunctional EGFP/sAPRIL fusion protein. Appl Microbiol Biotechnol 2007;73:1114-22. [PMID: 17021878 DOI: 10.1007/s00253-006-0591-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
520 Chan CC, Harley ITW, Pfluger PT, Trompette A, Stankiewicz TE, Allen JL, Moreno-Fernandez ME, Damen MSMA, Oates JR, Alarcon PC, Doll JR, Flick MJ, Flick LM, Sanchez-Gurmaches J, Mukherjee R, Karns R, Helmrath M, Inge TH, Weisberg SP, Pamp SJ, Relman DA, Seeley RJ, Tschöp MH, Karp CL, Divanovic S. A BAFF/APRIL axis regulates obesogenic diet-driven weight gain. Nat Commun 2021;12:2911. [PMID: 34006859 DOI: 10.1038/s41467-021-23084-1] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
521 Álvarez Román MT, Fernández Bello I, Arias-Salgado EG, de Paz R, Jiménez Yuste V, Martín Salces M, Butta NV. Effect of thrombopoietin-receptor agonists on a proliferation-inducing ligand (APRIL) plasma levels in patients with immune thrombocytopaenia. Br J Clin Pharmacol 2014;78:674-6. [PMID: 24602175 DOI: 10.1111/bcp.12370] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
522 Lee JJ, Rauter I, Garibyan L, Ozcan E, Sannikova T, Dillon SR, Cruz AC, Siegel RM, Bram R, Jabara H, Geha RS. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function. Blood 2009;114:2254-62. [PMID: 19605846 DOI: 10.1182/blood-2008-11-189720] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
523 Pekarsky Y, Croce CM. Role of miR-15/16 in CLL. Cell Death Differ. 2015;22:6-11. [PMID: 24971479 DOI: 10.1038/cdd.2014.87] [Cited by in Crossref: 115] [Cited by in F6Publishing: 100] [Article Influence: 16.4] [Reference Citation Analysis]
524 You F, Ren W, Gu S, Wang W, Zhou L, Zhang Y, Gan W, Chen M. First BAFF gene cloned from an aquatic mammal. Gene 2012;504:13-21. [DOI: 10.1016/j.gene.2012.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
525 Watanabe R, Fujimoto M, Yazawa N, Nakashima H, Asashima N, Kuwano Y, Tada Y, Maruyama N, Okochi H, Tamaki K. Increased serum levels of a proliferation-inducing ligand in patients with bullous pemphigoid. J Dermatol Sci 2007;46:53-60. [PMID: 17250993 DOI: 10.1016/j.jdermsci.2006.12.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
526 Yiwen Z, Shilin G, Yingshi C, Lishi S, Baohong L, Chao L, Linghua L, Ting P, Hui Z. Efficient generation of antigen-specific CTLs by the BAFF-activated human B Lymphocytes as APCs: a novel approach for immunotherapy. Oncotarget 2016;7:77732-48. [PMID: 27780916 DOI: 10.18632/oncotarget.12792] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
527 Coelho V, Saitovitch D, Kalil J, Silva HM. Rethinking the multiple roles of B cells in organ transplantation. Current Opinion in Organ Transplantation 2013;18:13-21. [DOI: 10.1097/mot.0b013e32835c8043] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 2.1] [Reference Citation Analysis]
528 De Re V, Caggiari L, Garziera M, De Zorzi M, Repetto O. Molecular signature in HCV-positive lymphomas. Clin Dev Immunol. 2012;2012:623465. [PMID: 22952554 DOI: 10.1155/2012/623465] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
529 Fanale MA, Younes A. Monoclonal Antibodies in the Treatment of Non-Hodgkin???s Lymphoma: . Drugs 2007;67:333-50. [DOI: 10.2165/00003495-200767030-00002] [Cited by in Crossref: 83] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]
530 Kaga H, Komatsuda A, Omokawa A, Ito M, Teshima K, Tagawa H, Sawada K, Wakui H. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE. Modern Rheumatology 2015;25:865-70. [DOI: 10.3109/14397595.2015.1030102] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
531 Zhou Z, Zhou Z, Chen Z, Zhou Z, Chen Z, Li H, Chen X, Xu J, Gu D, Du W, Zheng C, Zhang L, Huang Y, Ren Q, Yang R. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura. Autoimmunity 2009;42:112-9. [DOI: 10.1080/08916930802397848] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
532 Chen X, Ma J, Yao Y, Zhu J, Zhou Z, Zhao R, Dong X, Gao W, Zhang S, Huang S, Chen L. Metformin prevents BAFF activation of Erk1/2 from B-cell proliferation and survival by impeding mTOR-PTEN/Akt signaling pathway. Int Immunopharmacol 2021;96:107771. [PMID: 34004440 DOI: 10.1016/j.intimp.2021.107771] [Reference Citation Analysis]
533 Hall J, Dennler P, Haller S, Pratsinis A, Säuberli K, Towbin H, Walther K, Woytschak J. Genomics drugs in clinical trials. Nat Rev Drug Discov 2010;9:988-988. [DOI: 10.1038/nrd1552-c1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
534 Phares TW, Marques CP, Stohlman SA, Hinton DR, Bergmann CC. Factors supporting intrathecal humoral responses following viral encephalomyelitis. J Virol 2011;85:2589-98. [PMID: 21191015 DOI: 10.1128/JVI.02260-10] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
535 Weston VJ, Stankovic T. Rac1 and Rac2 GTPases in haematopoiesis. Bioessays 2004;26:221-4. [DOI: 10.1002/bies.20017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
536 Galián JA, Mrowiec A, Muro M. Molecular targets on B-cells to prevent and treat antibody-mediated rejection in organ transplantation. Present and Future. Expert Opinion on Therapeutic Targets 2016;20:859-67. [DOI: 10.1517/14728222.2016.1135904] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
537 Tangye SG. Staying alive: regulation of plasma cell survival. Trends Immunol 2011;32:595-602. [PMID: 22001488 DOI: 10.1016/j.it.2011.09.001] [Cited by in Crossref: 95] [Cited by in F6Publishing: 85] [Article Influence: 9.5] [Reference Citation Analysis]
538 Serafini B, Severa M, Columba-Cabezas S, Rosicarelli B, Veroni C, Chiappetta G, Magliozzi R, Reynolds R, Coccia EM, Aloisi F. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J Neuropathol Exp Neurol 2010;69:677-93. [PMID: 20535037 DOI: 10.1097/NEN.0b013e3181e332ec] [Cited by in Crossref: 100] [Cited by in F6Publishing: 43] [Article Influence: 9.1] [Reference Citation Analysis]
539 Zhang J, Ma H, Sang M, Hu Y, Liang Z, Ai H, Zhang J, Cui X, Zhang S. Molecular structure, expression, cell and tissue distribution, immune evolution and cell proliferation of the gene encoding bovine (Bos taurus) TNFSF13 (APRIL). Developmental & Comparative Immunology 2010;34:1199-208. [DOI: 10.1016/j.dci.2010.06.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
540 Bishton M, Spencer A, Dickinson M, Ritchie D. A single-arm, phase II study of the anti-Blys monoclonal antibody belimumab in symptomatic Waldenstrom macroglobulinemia. Clin Lymphoma Myeloma Leuk 2013;13:575-8. [PMID: 23773449 DOI: 10.1016/j.clml.2013.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
541 Shui Y, Guan Z, Zhang J, Zhang S. cDNA cloning, genomic structure, expression analysis and biological activity of porcine A Proliferation-Inducing Ligand (APRIL). Veterinary Immunology and Immunopathology 2008;125:190-7. [DOI: 10.1016/j.vetimm.2008.05.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
542 Page EK, Dar WA, Knechtle SJ. Biologics in organ transplantation. Transpl Int. 2012;25:707-719. [PMID: 22420711 DOI: 10.1111/j.1432-2277.2012.01456.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
543 Martin F, Dixit VM. Unraveling TACIt functions. Nat Genet 2005;37:793-4. [PMID: 16049503 DOI: 10.1038/ng0805-793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
544 Wang SL, Cai YF, Lin QP, Sheng XL, Shui Y, Zhang SQ. Molecular cloning, in vitro expression and bioactivity of dog A proliferation-inducing ligand (APRIL). Vet Immunol Immunopathol 2009;128:407-12. [PMID: 19117611 DOI: 10.1016/j.vetimm.2008.11.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
545 Ding H, Wang L, Wu X, Yan J, He Y, Ni B, Gao W, Zhong X. Blockade of B-cell-activating factor suppresses lupus-like syndrome in autoimmune BXSB mice. J Cell Mol Med 2010;14:1717-25. [PMID: 19627403 DOI: 10.1111/j.1582-4934.2009.00817.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
546 Yi Z, Lin WW, Stunz LL, Bishop GA. Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions. Cytokine Growth Factor Rev 2014;25:147-56. [PMID: 24433987 DOI: 10.1016/j.cytogfr.2013.12.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
547 Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3:745-756. [PMID: 12949498 DOI: 10.1038/nri1184] [Cited by in Crossref: 1766] [Cited by in F6Publishing: 1604] [Article Influence: 98.1] [Reference Citation Analysis]
548 Kriegsmann K, Kriegsmann M, Cremer M, Schmitt M, Dreger P, Goldschmidt H, Müller-Tidow C, Hundemer M. Cell-based immunotherapy approaches for multiple myeloma. Br J Cancer 2019;120:38-44. [PMID: 30518815 DOI: 10.1038/s41416-018-0346-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
549 Weldon AJ, Moldovan I, Cabling MG, Hernandez EA, Hsu S, Gonzalez J, Parra A, Benitez A, Daoud N, Colburn K, Payne KJ. Surface APRIL Is Elevated on Myeloid Cells and Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. J Rheumatol 2015;42:749-59. [PMID: 25729037 DOI: 10.3899/jrheum.140630] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
550 Panzer SE. Anti-BAFF Therapy: A New Tool to Target B Cells in Antibody-mediated Rejection? Transplantation 2020;104:e3-4. [PMID: 31596742 DOI: 10.1097/TP.0000000000002993] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
551 Baek A, Park HJ, Na S, Shim DS, Moon J, Yang Y, Choi Y. The expression of BAFF in the muscles of patients with dermatomyositis. Journal of Neuroimmunology 2012;249:96-100. [DOI: 10.1016/j.jneuroim.2012.04.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
552 Mabuka JM, Dugast AS, Muema DM, Reddy T, Ramlakhan Y, Euler Z, Ismail N, Moodley A, Dong KL, Morris L, Walker BD, Alter G, Ndung'u T. Plasma CXCL13 but Not B Cell Frequencies in Acute HIV Infection Predicts Emergence of Cross-Neutralizing Antibodies. Front Immunol 2017;8:1104. [PMID: 28943879 DOI: 10.3389/fimmu.2017.01104] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
553 Faner R, Cruz T, Casserras T, López-Giraldo A, Noell G, Coca I, Tal-Singer R, Miller B, Rodriguez-Roisin R, Spira A, Kalko SG, Agustí A. Network Analysis of Lung Transcriptomics Reveals a Distinct B-Cell Signature in Emphysema. Am J Respir Crit Care Med 2016;193:1242-53. [PMID: 26735770 DOI: 10.1164/rccm.201507-1311OC] [Cited by in Crossref: 59] [Cited by in F6Publishing: 36] [Article Influence: 14.8] [Reference Citation Analysis]
554 Turner JS, Benet ZL, Grigorova IL. Signals 1, 2 and B cell fate or: Where, when and for how long? Immunol Rev 2020;296:9-23. [DOI: 10.1111/imr.12865] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
555 Stefanich EG, Ren S, Danilenko DM, Lim A, Song A, Iyer S, Fielder PJ. Evidence for an asialoglycoprotein receptor on nonparenchymal cells for O-linked glycoproteins. J Pharmacol Exp Ther 2008;327:308-15. [PMID: 18728239 DOI: 10.1124/jpet.108.142232] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
556 Li R, Rezk A, Healy LM, Muirhead G, Prat A, Gommerman JL, Bar-Or A; MSSRF Canadian B cells in MS Team. Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis. Front Immunol 2015;6:626. [PMID: 26779181 DOI: 10.3389/fimmu.2015.00626] [Cited by in Crossref: 27] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
557 Hu S, Wang R, Zhang M, Liu K, Tao J, Tai Y, Zhou W, Wang Q, Wei W. BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway. Biomed Pharmacother 2019;114:108796. [PMID: 30921706 DOI: 10.1016/j.biopha.2019.108796] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
558 Castigli E, Scott S, Dedeoglu F, Bryce P, Jabara H, Bhan AK, Mizoguchi E, Geha RS. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci USA. 2004;101:3903-3908. [PMID: 14988498 DOI: 10.1073/pnas.0307348101] [Cited by in Crossref: 321] [Cited by in F6Publishing: 292] [Article Influence: 18.9] [Reference Citation Analysis]
559 Moens L, Tangye SG. Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage. Front Immunol 2014;5:65. [PMID: 24600453 DOI: 10.3389/fimmu.2014.00065] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 13.6] [Reference Citation Analysis]
560 Mcclure M, Gopaluni S, Jayne D, Jones R. B cell therapy in ANCA-associated vasculitis: current and emerging treatment options. Nat Rev Rheumatol 2018;14:580-91. [DOI: 10.1038/s41584-018-0065-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
561 Peter HH, Warnatz K. Molecules involved in T-B co-stimulation and B cell homeostasis: possible targets for an immunological intervention in autoimmunity. Expert Opin Biol Ther 2005;5 Suppl 1:S61-71. [PMID: 16187941 DOI: 10.1517/14712598.5.1.s61] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
562 Cerutti A, Qiao X, He B. Plasmacytoid dendritic cells and the regulation of immunoglobulin heavy chain class switching. Immunol Cell Biol 2005;83:554-62. [PMID: 16174107 DOI: 10.1111/j.1440-1711.2005.01389.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
563 Moreaux J, Sprynski AC, Dillon SR, Mahtouk K, Jourdan M, Ythier A, Moine P, Robert N, Jourdan E, Rossi JF, Klein B. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop. Eur J Haematol 2009;83:119-29. [PMID: 19456850 DOI: 10.1111/j.1600-0609.2009.01262.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 6.1] [Reference Citation Analysis]
564 Delaleu N, Manoussakis MN, Moutsopoulos HM, Jonsson R. Etiology and Pathogenesis of Sjögren’s Syndrome with Special Emphasis on the Salivary Glands. In: Fox RI, Fox CM, editors. Sjögren’s Syndrome. New York: Springer; 2012. pp. 243-67. [DOI: 10.1007/978-1-60327-957-4_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
565 Thangarajh M, Masterman T, Hillert J, Moerk S, Jonsson R. A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis. Scand J Immunol 2007;65:92-8. [PMID: 17212772 DOI: 10.1111/j.1365-3083.2006.01867.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
566 Rossi JF. Targeted Therapies in Adult B-Cell Malignancies. Biomed Res Int 2015;2015:217593. [PMID: 26425544 DOI: 10.1155/2015/217593] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
567 Lee WH, Seo D, Lim SG, Suk K. Reverse Signaling of Tumor Necrosis Factor Superfamily Proteins in Macrophages and Microglia: Superfamily Portrait in the Neuroimmune Interface. Front Immunol 2019;10:262. [PMID: 30838001 DOI: 10.3389/fimmu.2019.00262] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
568 Lightman SM, Utley A, Lee KP. Survival of Long-Lived Plasma Cells (LLPC): Piecing Together the Puzzle. Front Immunol 2019;10:965. [PMID: 31130955 DOI: 10.3389/fimmu.2019.00965] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 19.5] [Reference Citation Analysis]
569 Moon EY, Kang JS, Han SH, Yang KH, Pyo S, Lee MY, Lee HK, Yu DY. Differential role of peroxiredoxin II (PrxII) on the expression of toll-like receptor 4 (TLR4) and B-cell activating factor (BAFF) in ovalbumin (OVA)-induced mouse asthma. Int Immunopharmacol 2008;8:935-44. [PMID: 18442801 DOI: 10.1016/j.intimp.2008.01.022] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
570 Carbonatto M, Yu P, Bertolino M, Vigna E, Steidler S, Fava L, Daghero C, Roattino B, Onidi M, Ardizzone M, Peano S, Visich J, Janszen D, Dillon S, Ponce R. Nonclinical safety, pharmacokinetics, and pharmacodynamics of atacicept. Toxicol Sci 2008;105:200-10. [PMID: 18522929 DOI: 10.1093/toxsci/kfn105] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
571 Hyun J, Kanagavelu S, Fukata M. A unique host defense pathway: TRIF mediates both antiviral and antibacterial immune responses. Microbes Infect 2013;15:1-10. [PMID: 23116944 DOI: 10.1016/j.micinf.2012.10.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
572 Novak AJ, Darce JR, Arendt BK, Harder B, Henderson K, Kindsvogel W, Gross JA, Greipp PR, Jelinek DF. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood 2004;103:689-94. [PMID: 14512299 DOI: 10.1182/blood-2003-06-2043] [Cited by in Crossref: 333] [Cited by in F6Publishing: 291] [Article Influence: 18.5] [Reference Citation Analysis]
573 Day ES, Cachero TG, Qian F, Sun Y, Wen D, Pelletier M, Hsu Y, Whitty A. Selectivity of BAFF/BLyS and APRIL for Binding to the TNF Family Receptors BAFFR/BR3 and BCMA. Biochemistry 2005;44:1919-31. [DOI: 10.1021/bi048227k] [Cited by in Crossref: 115] [Cited by in F6Publishing: 102] [Article Influence: 7.2] [Reference Citation Analysis]
574 Creusot RJ, Fathman CG, Müller-Ladner U, Tarner IH. Targeted gene therapy of autoimmune diseases: advances and prospects. Expert Rev Clin Immunol 2005;1:385-404. [PMID: 20476990 DOI: 10.1586/1744666X.1.3.385] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
575 Kompoti M, Michopoulos A, Michalia M, Clouva-Molyvdas PM, Germenis AE, Speletas M. Genetic polymorphisms of innate and adaptive immunity as predictors of outcome in critically ill patients. Immunobiology 2015;220:414-21. [PMID: 25454804 DOI: 10.1016/j.imbio.2014.10.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
576 Pallier A, Hillion S, Danger R, Giral M, Racapé M, Degauque N, Dugast E, Ashton-Chess J, Pettré S, Lozano JJ. Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int. 2010;78:503-513. [PMID: 20531452 DOI: 10.1038/ki.2010.162] [Cited by in Crossref: 197] [Cited by in F6Publishing: 175] [Article Influence: 17.9] [Reference Citation Analysis]
577 Cancro MP. B cells and aging: gauging the interplay of generative, selective, and homeostatic events. Immunol Rev 2005;205:48-59. [DOI: 10.1111/j.0105-2896.2005.00272.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
578 Yarkoni Y, Getahun A, Cambier JC. Molecular underpinning of B-cell anergy. Immunol Rev 2010;237:249-63. [PMID: 20727040 DOI: 10.1111/j.1600-065X.2010.00936.x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 43] [Article Influence: 7.7] [Reference Citation Analysis]
579 Heltemes-harris L, Liu X, Manser T. An antibody VH gene that promotes marginal zone B cell development and heavy chain allelic inclusion. International Immunology 2005;17:1447-61. [DOI: 10.1093/intimm/dxh323] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
580 Bortnick A, Chernova I, Spencer SP, Allman D. No strict requirement for eosinophils for bone marrow plasma cell survival. Eur J Immunol 2018;48:815-21. [PMID: 29442367 DOI: 10.1002/eji.201747229] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
581 Fletcher C, Sutherland A, Groom J, Batten M, Ng L, Gommerman J, Mackay F. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells. Eur J Immunol 2006;36:2504-14. [DOI: 10.1002/eji.200636270] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
582 Patel DR, Wallweber HJ, Yin J, Shriver SK, Marsters SA, Gordon NC, Starovasnik MA, Kelley RF. Engineering an APRIL-specific B Cell Maturation Antigen. Journal of Biological Chemistry 2004;279:16727-35. [DOI: 10.1074/jbc.m312316200] [Cited by in Crossref: 40] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
583 Guo W, Qu X, Yang M, Zhang W, Liang L, Shao Q, Kong B. Expression of BAFF in the trophoblast and decidua of normal early pregnant women and patients with recurrent spontaneous miscarriage: . Chinese Medical Journal 2008;121:309-15. [DOI: 10.1097/00029330-200802020-00006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
584 Yazbeck V, Georgakis GV, Wedgwood A, Younes A. Hodgkin's lymphoma: molecular targets and novel treatment strategies. Future Oncol 2006;2:533-51. [PMID: 16922620 DOI: 10.2217/14796694.2.4.533] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
585 Abe J, Ueha S, Yoneyama H, Shono Y, Kurachi M, Goto A, Fukayama M, Tomura M, Kakimi K, Matsushima K. B cells regulate antibody responses through the medullary remodeling of inflamed lymph nodes. Int Immunol 2012;24:17-27. [PMID: 22190575 DOI: 10.1093/intimm/dxr089] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
586 Matthes T, Dunand-Sauthier I, Santiago-Raber ML, Krause KH, Donze O, Passweg J, McKee T, Huard B. Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow. Blood 2011;118:1838-44. [PMID: 21642598 DOI: 10.1182/blood-2011-01-332940] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 6.3] [Reference Citation Analysis]
587 Cueto-sola M, Bailon E, Utrilla P, Rodríguez-ruiz J, Garrido-mesa N, Zarzuelo A, Xaus J, Gálvez J, Comalada M. Active Colitis Exacerbates Immune Response to Internalized Food Antigens in Mice. Int Arch Allergy Immunol 2013;162:214-24. [DOI: 10.1159/000353596] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
588 Kalled SL. The role of BAFF in immune function and implications for autoimmunity. Immunol Rev 2005;204:43-54. [PMID: 15790349 DOI: 10.1111/j.0105-2896.2005.00219.x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 77] [Article Influence: 5.7] [Reference Citation Analysis]
589 Kobayashi T, Kim TS, Jacob A, Walsh MC, Kadono Y, Fuentes-Pananá E, Yoshioka T, Yoshimura A, Yamamoto M, Kaisho T. TRAF6 is required for generation of the B-1a B cell compartment as well as T cell-dependent and -independent humoral immune responses. PLoS One. 2009;4:e4736. [PMID: 19270748 DOI: 10.1371/journal.pone.0004736] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
590 Komatsuda A, Wakui H, Iwamoto K, Ozawa M, Togashi M, Masai R, Maki N, Hatakeyama T, Sawada K. Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol 2008;152:482-7. [PMID: 18373699 DOI: 10.1111/j.1365-2249.2008.03646.x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 102] [Article Influence: 8.5] [Reference Citation Analysis]
591 Salzer U, Chapel HM, Webster AD, Pan-Hammarström Q, Schmitt-Graeff A, Schlesier M, Peter HH, Rockstroh JK, Schneider P, Schäffer AA. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet. 2005;37:820-828. [PMID: 16007087 DOI: 10.1038/ng1600] [Cited by in Crossref: 475] [Cited by in F6Publishing: 390] [Article Influence: 29.7] [Reference Citation Analysis]
592 Rodig SJ, Shahsafaei A, Li B, Mackay CR, Dorfman DM. BAFF-R, the major B cell-activating factor receptor, is expressed on most mature B cells and B-cell lymphoproliferative disorders. Hum Pathol 2005;36:1113-9. [PMID: 16226112 DOI: 10.1016/j.humpath.2005.08.005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 3.0] [Reference Citation Analysis]
593 Kang JS, Yoon YD, Ahn JH, Kim SC, Kim KH, Kim HM, Moon EY. B cell-activating factor is a novel diagnosis parameter for asthma. Int Arch Allergy Immunol 2006;141:181-8. [PMID: 16899986 DOI: 10.1159/000094897] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]